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Chapter 1: Introduction   
Snakes are limbless predators that have evolved two different ways of incapacitating prey: suffocation 
and envenomation. The evolution of these life-history strategies lie in close relation with the evolution of 
body-elongation and limblessness.  Taken together, these adaptations underlie the massive radiation of 
snakes which occurred after the K-T boundary and extinction of the dinosaurs, presumably because 
multiple niches became available and many of their predators got extinct. In this thesis, I examine the 
evolution of these adaptations. A general question to address would be: what underlies these adaptations 
in snakes and how do they correspond with their ecology? In addition to these evolutionary questions, I 
also provide a summary in chapter one on the current status of using snake venom toxins in drug 
discovery and design, because the evolution of venom is closely related to the evolution of a serpentine 
body form and fangs, but also to the question of “why” snake venom is so interesting for the 
pharmacological prospector. The high potency and specifity of snake venom toxins is generated by 
millions of years of evolution and strong selective pressures, so it is my believe that the different chapters 
in my thesis are tightly bound together.  It is believed that it was Aristotle who first suggested – on the 
basis of symptoms observed in snakebite victims – that snakes may also be used to cure certain diseases 
(it was not yet known that venom was responsible for the observed effects). And in 1835 venom was 
already (although unsuccessfully) used to treat rabies. This field of “bioprospecting” has accelerated 
especially in the last decade, mainly because the development of many new sequencing and screening 
techniques. In chapter two, we go into the development and evolution of the different snake venom-
conducting fangs. This has been a matter of great controversy among scientists for the last century and 
many different hypotheses have been proposed. This was particularly because the two groups of snakes 
with fangs in the front of their upper jaw (Elapidae and Viperidae), have only relatively recently in the 
90s been shown not to form a monophyletic group, hinting towards an independent origin and evolution 
of front fangs. By using modern techniques such as in situ hybridization of snake embryos, and careful 
histological analysis we were able to reconstruct the evolutionary history and make a solid hypothesis for 
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the origin and evolution of fangs. In the third chapter of this thesis we look at the evolution of body-
elongation and deregionalization in snakes, since that presumably has also been a major driver of venom 
evolution by providing the ability for snakes to coil up and act as coiled spring that can strike and 
envenomate prey at a distance. Since Hox determine the basic structure of an embryo we have performed 
many in situ hybridisations in snake embryos and carefully compared the expression profiles of different 
Hox genes. For the fourth chapter of this thesis we sequenced a draft genome of the largest venomous 
snake in the world, the king cobra (Ophiophagus hannah) and annotated many of its venom genes. We 
wanted to find out whether we could find evidence of gene duplication and / or gene modification of 
physiological genes for use in the venom gland.  The birth-and-death model of gene evolution is the 
canonical framework for venom evolution, but was never actually thoroughly studies due to lack of 
genomic resources. Our genomic sequences let us study the king cobra venom genes in relation to its 
‘normal’ physiological genes. In the fifth chapter, we have set out to develop a new efficient and rapid 
method of analysing snake venom mixtures and performing a biological assay at the same time. We used 
the acetylcholine binding protein (AChBP) as biological target, because acetylcholine receptors are also 
often involved in neurological disorders, such as Alzheimer’s and Myasthenia gravis. In the last chapter 
of this thesis, I discuss this work and try to put it into broader perspective. The field of evolutionary 
genomics, molecular evolution as well as bioprospecting is huge and broad. However, I strongly believe 
that working on the edge of different scientific disciplines will provide you with a better understanding of 
nature and allows you to answer more questions.  
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Chapter 2: Snake venom: from fieldwork to the clinic.   
Vonk FJ, Jackson K, Doley R, Madaras F, Mirtschin PJ and N Vidal.  
This chapter has been published as 'cover article' in BioEssays 33, 269-79 (2011). 
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Abstract 
Snake venoms are recognized here as a grossly under-explored resource in pharmacological 
prospecting. Discoveries in snake systematics demonstrate that former taxonomic bias in research 
has led to the neglect of thousands of species of potential medical use. Recent discoveries reveal an 
unexpectedly vast degree of variation in venom composition among snakes, from different species 
down to litter mates. The molecular mechanisms underlying this diversity are only beginning to be 
understood. However, the enormous potential that this resource represents for pharmacological 
prospecting is clear. New high-throughput screening systems offer greatly increased speed and 
efficiency in identifying and extracting therapeutically useful molecules. At the same time a global 
biodiversity crisis is threatening the very snake populations on which hopes for new venom-derived 
medications depend. Biomedical researchers, pharmacologists, clinicians, herpetologists and 
conservation biologists must combine their efforts if the full potential of snake venom derived 
medications is to be realized. 
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Introduction  
Snakes are represented on earth today by some 3150 species 1 . Of these the vast majority (ca. 2700 
species, see Fig. 1) represent a single massive diversification event which occurred after the K-T 
boundary and extinction of the dinosaurs. This large and relatively recent group is known as Caenophidia 
or “advanced snakes” and characterized by the possession of a venom-delivery system or components of 
such a system 2. Snakes traditionally considered venomous are the 600 or so species with tubular front 
fangs, muscularized venom glands, and a bite significantly dangerous to humans (Viperidae, Elapidae and 
Atractaspidinae) - including well-known examples as the cobras, seasnakes, vipers and rattlesnakes. The 
remaining caenophidians were traditionally classified as “Colubridae”, meaning snakes with a venom 
gland  whose venom poses no danger to humans, and who lack the fangs at the front of the mouth for 
injecting it. The “Colubridae” has been shown to be paraphyletic, and most of its subfamilies have 
recently been elevated to a familial rank in order to reflect their evolutionary distinctiveness (Fig. 1) 1,3.  
“Colubrid” snakes have been largely neglected in venom research, because of the sole fact that bites have 
not been perceived as of medical importance, except few species as the African boomslang  (Dispholidus 
typus) and twigsnakes (Thelotornis spp.) and the Asian yamakagashi (Rhabdophis tigrinus). However, 
during the last few years, there has been a trend towards studying the venoms of these harmless venomous 
snakes to, primarily, increase our understanding of venom evolution. It became evident that these 
harmless snakes do secrete a strong acting venom with powerful toxins, although in a significantly lower 
amount and without an efficient injection mechanism 2,4. This influenced the ongoing quest for venom 
molecules that may be useful in fighting human disease - a snake need not be dangerous to humans for its 
venom to still have a profound effect upon the human body. This field of biodiscovery is now rapidly 
emerging, especially due to the development of modern high-throughput screening assays that allow rapid 
identification of potential therapeutic agents. 
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Figure 1 | Phylogenetic tree showing the distribution of 28 snake venom protein families among advanced snakes, with the 
number of currently known species of each family and the number of red listed species. Families in grey used to make up the old 
traditional “Colubridae”. Phylogeny based on 1,5. 
Snake venom contains a mixture of powerful proteins and peptides that have evolved to be targeted to 
receptors, ion channels or enzymes 6, in addition to some carbohydrates, nucleosides, lipids, and metal 
ions, whose functions are not all known 7,8. They interact with a wide variety of mammalian proteins and 
can disrupt the central and peripheral nervous systems, the blood coagulation cascade, the cardiovascular 
and neuromuscular systems, and homeostasis in general. These venom proteins act with great precision – 
different toxins recognize different subtypes of certain receptors with only subtle differences – and are 
very biologically active.  The precision and power with which they work lies right at the centre of why 
they form such a valuable resource to biochemists, biomedical researchers, evolutionary biologists and 
others.  
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Several major human drugs or diagnostics have been developed based on snake venom 
components. In addition, some fundamental biological processes have been revealed by using toxins as 
probes to study cells and their receptors. Here we review the state of this field and emphasize that the 
emerging field of high-throughput screening assays applied to a wide range of unstudied venoms, has the 
potential to provide a solid basis for the discovery of new lead compounds for new drugs.   
Forces driving evolutionary divergence in venom composition: diet, phylogeny, 
biogeography and ontogeny 
Only in relatively recent years has the remarkable variability of venom composition at the genus, species, 
subspecies, population and even individual levels been fully appreciated, and the underlying ecological 
forces and mechanisms of mutation at the molecular level started to be identified and understood. 
Variation in venom composition has far-reaching implications. For the treatment of snakebite, for 
example, the importance of using pooled venom (mixtures of venom from several individuals of the same 
species representing different ages and geographical origins) has been emphasized in the production of 
antivenom to – in some cases - produce a serum that will be maximally effective against a bite from any 
snake of that species 9. However, it should be noted that many antivenoms provide excellent – sometimes 
even better – cross reactions against antigens not even included in the original mixture, a phenomenon 
which is not yet well understood.   
Since different species of prey differ in their physiological reaction to venom molecules, it 
follows that venom composition is linked to diet and varies from the species level all the way to 
individuals. In saw-scaled vipers (Echis), venom from those species that feed on arthropods was highly 
toxic to scorpions 10. By contrast, scorpions were unaffected by venom from those species that feed on 
mammals 10. Phylogenetic analysis revealed repeated instances of co-evolution of venom composition 
with prey preference. Other examples of variation in venom composition, at the individual to the species 
level, correlated with diet have been found in coral snakes (Micrurus) 11, rattlesnakes (Crotalus and 
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Sistrurus) 9,12-14, Malayan pitvipers (Calloselasma) 15, lanceheads (Bothrops) 16,17, puff adders (Bitis 
arietans) 18, and others.  
Specificity of venom to prey type has also been found by studies approaching the question by 
analyzing the composition of the venom. A single species of coral snake (Micrurus s. surinamensis), 
distinctive within its genus in feeding on fish, was found to have venom containing neurotoxins lethal to 
fish and not known from the venom of other Micrurus species 11. Significant differences in the protein 
composition were also found in the venoms of three subspecies of the rattlesnake Sistrurus catenatus, 
attributable to dietary differences between the subspecies 19. Of the 11 protein families represented in the 
venom of this species, variation between the subspecies was found in all protein families, but variation 
was greater in some than in others. The metalloproteinases proved to be the most conserved while the 
PLA2s were the most divergent. PLA2s are often associated with neurotoxins – i.e the neurotoxin 
molecules also have PLA2 activity (e.g. notexin, taipoxin, crotoxin, β-Bungarotoxin etc.), so it could be 
that the neurotoxins vary more to accommodate the  different prey types.    Some toxins may assist in 
prey breakdown (digestion) but others – like neurotoxins causing paralysis or haemotoxins causing rapid 
low blood pressure or circulation – are perhaps more critical, they may determine whether the snake gets 
the meal in the first place.  
In addition to diet, other variables such as phylogeny, biogeography and ontogeny may also be 
forces driving the evolutionary divergence of venom proteins (these factors may well be correlated with 
diet in many cases) – and perhaps just even separation time between populations due to genetic drift 20. 
Although most studies documenting variation attribute it to a single factor, considering these categories in 
isolation may result in an incomplete understanding of the true scenario. For example, individuals of the 
common lancehead (Bothrops asper)  from two different localities and of different ages displayed 
significant differences in venom proteome 21. Variation in symptoms of bite victims from individuals of 
this species varying in age or geographic origin has been observed though never formally documented. 
Ontogenetic differences in venom compositions are most probably explained by ontogenetic shifts in diet 
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22. The venom of neonates was found to differ significantly from that of adults, with a trend toward 
increasing complexity with age 22. In the proteomes of neonate and adult individuals of the rattlesnake 
Crotalus simus the venom of adults and neonates had only 50% of their proteome in common, with a 
trend from neurotoxic changing to hemorrhagic properties from neonate to adult 23.  
While ontogenetic variation certainly, and biogeographical variation in some cases, may well be 
explained by variation in prey type, observations of variation in the venom proteome of male versus 
female neonates from a single litter of the South American viper Bothrops jararaca 24 are puzzling and 
underscore just how much remains to be learned about the evolutionary forces driving variation in venom 
composition.  
For the pharmacological prospector, variation is right at the heart of the potential goldmine of 
molecules that snake venom represents since a high degree of variation in venom composition increases 
the number of potentially useful novel molecules. Recognizing the crucial biomedical significance of 
variation in venom underscores the importance of efforts by those field biologists working with snakes to 
understand and conserve biological diversity, from the species down to the individual level. This 
emphasizes the importance of fieldwork in biodiscovery and the collection of venom samples from a wide 
range of species and specimens of different geographical localities and ages (Fig. 2).  
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Figure 2 | Due to the enormous diversity in venom composition and the accelerated evolution of different isoforms of each of the 
toxin types in Fig. 1, fieldwork is essential to obtain samples from a wide range of species and specimens of different 
geographical localities and ages to exploit the full pharmacological potential of venom. A: a rare species of “colubrid”, the green 
tree snake (Dipsadoboa viridis), in the Republic of Congo (Africa), photo by K.J. B: one of the authors (F.J.V.) with a wild king 
cobra (Ophiophagus hannah) – the longest venomous snake in the world - on the island of Java in Indonesia, photo by Smarley. 
C. The same author obtaining a venom sample from an Australian King brown (Pseudechis rossignoli), photo by H-W Herrmann. 
D. one of the authors (K.J.) removing a watersnake (Grayia ornata), mimic of the venomous Water cobra (Naja annulata) from a 
net in the Republic of Congo. 
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Sources of toxin diversity: multiple splicing, exon insertion, exon switching, post-
translational modification and domain switching 
Snake toxin genes are the result of gene-duplications of normal body proteins that are subsequently 
selectively expressed in the venom gland 25, often followed by accelerated point mutations in the protein 
coding regions 26. Gene duplication creates redundancy and allows the duplicated gene to escape the 
pressures of negative selection and acquire new functions through accelerated adaptive molecular 
evolution 26. Acetylcholinesterase is the only currently known exception, because both the toxin and the 
normal enzyme are encoded by the same gene but differentially expressed using alternative splicing 27.  
The molecular mechanisms that cause accelerated evolution – a bias towards nucleotide 
mutations that lead to amino acid changes (nonsynonymous substitutions) compared to those that don’t 
(synonymous substitutions) – are currently not understood. When the first snake genome becomes 
available, this may shed light upon the molecular mechanisms that operate on the venom genes. 
Interestingly, nucleotide sequences appear to determine the accelerated rate of point mutations 27. Specific 
triplets were found to be more ‘stable’ with regards to mutations than others, and the stable triplets were 
found to be higher in abundance in venom introns while the non-stable triplets were found higher in 
abundance in venom exons. There also appears to be a bias for transversions over transitions in nucleotide 
substitutions in some toxins 28.  
There are several mechanisms by which molecular diversity of venom toxins is generated. First, 
alternative splicing allows multiple different functional proteins to be created using the same exons (Fig. 
3a) 29,30 as it may cause binding to different receptors 31 or change of target altogether. Second, exons may 
be inserted  into existing genes - as in denmotoxin (Fig. 3b), a three-finger toxin in the venom of the 
“colubrid” mangrove catsnake (Boiga dendrophila) with bird-specific activity 32. Third, part of the intron 
may be retained in the mRNA due to error in splicing (Fig. 3c).  Also, a recent discovered mechanism 
termed accelerated segment switch in exons to alter targeting (ASSET) may play an important role in 
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generating the molecular diversity in snake venom molecules 33 (Fig. 3d). During ASSET certain parts of 
exons are changed through accelerated segment switch and generate a functionally new toxin with a 
conserved structural fold. Sometimes, synergistic action between two different toxins may enhance their 
potency 34,35.  
Post-translational modifications such as disulphide bridge formation and proteolysis play 
important roles in structural modification and acquisition of new functional sites. Both covalent and non-
covalent interactions between similar and dissimilar proteins can form complexes that may exhibit a much 
higher pharmacological activity compared to the individual components. Sometimes formation of 
hetero/homo dimeric or trimeric complexes may lead to recognition of new targets as protein-protein 
interaction in complexes may expose critical amino acid residues that were otherwise buried in monomers 
28.  
New interaction sites are also formed in certain proteins to exhibit higher pharmacological potencies 
through domain swapping. In domain swapping, exchange of identical structural elements takes place 
between two or more molecules to form dimers or oligomers. For example, with the exchange of domains 
by α and β subunits of IX/X binding protein, isolated from the venom of the Okinawa habu 
(Protobothrops flavoviridis) 36, the hinge region forms a concave structure between the subunits and 
provides a new functional site in the heterodimer 28. Without this swapping the loop would fold back and 
the ligand binding site would be absent.  
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Figure 3 |  Some molecular mechanisms by which the diversity of toxin proteins is achieved. A: normal and alternative splicing. 
B: insertion of exon, as in denmotoxin 32. C: intron retention due to error in splicing. D: accelerated segment switch in exons to 
alter targeting (ASSET) sas in a 3FTX from the venom of the rattlesnake Sistrurus catenatus 33. Colored segments (red, purple, 
pink, yellow) represent exchanges of segments. 
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Snake venom enzymes and toxins  
Of the following enzymes, some have currently been described in all snake venoms, and others from only 
a limited number of species: PLA2s, metalloproteinases, serine proteases, acetylcholinesterases, LAOs, 
and hyaluronidases (Fig. 1).  Two important and diverse families are the PLA2s and the 
metalloproteinases. PLA2 enzymes exhibit a wide variety of pharmacological effects in prey/victims  and 
are therefore interesting for the pharmacological prospector  37. Catalytically inactive Lys49 PLA2 homologs 
– found in many viperid venoms and being strongly myotoxic – work through a mechanism independent of 
hydrolysis 38. Furthermore, although different in their pharmacological and enzymatic activity, the PLA2-like 
and PLA2 toxins are highly similar in sequence and structure and differ only for the substation of Asp-49 
with Lys or Ser 39 - an example of how puzzling the mechanisms of toxicity can be. Some of the neurotoxic 
PLA2 are either homo/heterodimeric complexes. For example,  β–bungarotoxin  contains a covalently linked 
kunitz-type serine protease inhibitor  which is involved in the blocking activity 40.  
SVMPs are responsible for major local symptoms in snakebite - causing hemorrhage, edema, 
hypotension, hypovolemia, inflammation and necrosis. They are divided into three groups (P-I to P-III) 
based on the presence of other domains in the mature protein 41. PI SVMP’s have a prodomain and a 
single metalloproteinase domain that overall causes less hemorrhagic action then the other types, but still 
displays a variety of biological activities. The PII SVMP’s are composed of a metalloproteinase and 
disintegrin domain, along with a prodomain.  
Non-enzymatic venom proteins include 3FTXs, Kunitz-type serine protease inhibitors, 
sarafotoxins, CRISP, disintegrins, C-type lectins, waprins, veficolins and vespryns.  3FTXs have three 
beta-stranded loops resembling three-fingers and are mainly found in the venoms of elapids, some 
“colubrids” 32,42 and, in low quantity, in some viperids 43,44. The structure is stabilized by four conserved 
disulphide bridges 45,46. However, these structurally related molecules differ greatly in their biological 
functions 47,48. Functional characterization of this family of proteins has contributed significantly to our 
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understanding of the mechanisms of venom toxicity and of normal physiological processes 48. For 
example, characterization of α-bungarotoxin, a three-finger neurotoxin found in the venom of the banded 
krait (Bungarus multicinctus), enabled the isolation of the human nAChR 49 and contributed to our 
understanding of myasthenia gravis 50. Significant contributions have been made in determining the 
distribution of specific receptors or ion channels in particular tissues or cells, identification of subtypes of 
receptors, imaging receptor trafficking 51-53 as well as in the development of therapeutic agents for 
treatment of adrenomyeloneuropathy and multiple sclerosis 54.  
Snake venom kunitz-type serine protease inhibitors like dendrotoxin, calcicludine and the B chain 
of β-bungarotoxin, act as Ca2+ and K+ channel blockers respectively 55-57. Textilinin, a kunitz-type serine 
protease inhibitor from the venom of the highly dangerous Australian brown snake (Pseudonaja textilis) 
is a reversible plasmin inhibitor and has promising potential for development of anti-bleeding agent 58.  
Waprins have only recently been identified in snake venom and show homology to whey acidic 
proteins 59. So far their functions are not really understood except for omwaprin, isolated from the Inland 
taipan (Oxyuranus microlepidotus), which possesses selective antimicrobial activities 60, useful for 
developing potential antibiotics. 
CRISP toxins have molecular weights of 20-30 kDa and 16 conserved cysteine residues. 
Functional characterization of some CRISP has revealed that they are involved in blocking cyclic 
nucleotide-gated ion channels and block potassium-stimulated smooth muscle contraction 61. Therefore in 
addition to their involvement in disrupting the normal physiological functions of victims they can be used 
for studying ion channel chemistry. A CRISP toxin from the venom of the “colubrid” snake the Patagonia 
green racer (Philodryas patagoniensis) was recently shown to cause damage to the murine gastrocnemius 
muscle, an action never before shown for any CRISP toxin 62 – showing the potential “colubrid” venoms 
have to find new toxins.   
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Snaclecs comprise two subclasses of protein, C-type lectins (CTLs) and C-type lectin-related 
proteins (CLRPs), found in venoms of most families of advanced snakes. Snake venom CTLs  are 
involved in hemagglutinating and platelet aggregation activities during envenomation 63-66. The CLRPs 
are involved in anticoagulant, procoagulant and agonist/antagonist of platelet activation 67,68. 
Pharmacological characterization reveals that they either enhance or inhibit the function of coagulation 
factors which underscores their potential in drug discovery for blood related diseases. Their immaculate 
specificity also helps in understanding platelet physiology. 
Disintegrins are a class of non-enzymatic that bind to integrins  
expressed on platelets and other vascular endothelial cells as well as some tumor cells 69 – they are an 
important class of cell surface receptors that are critically involved in cell–cell and cell–matrix 
interactions and are therefore good candidates to understand the interaction between extracellular matrix 
and cells 70. In addition to their role in antiplatelet activity, these molecules are used in the diagnosis of 
cardiovascular diseases as well as serving as prototypes for therapeutic molecules in treatment of cancer.  
The medicinal use of snake venom 
A large number of venom proteins affect the haemostatic system 71 and can have procoagulant, 
anticoagulant, fibrinolytic or platelet active activities. Ancrod (Arvin) from the venom of the Malayan 
pitviper (Calloselasma rhodostoma), Batroxobin (Reptilase) from the common lancehead (Bothrops 
atrox), Crotalase from the Eastern diamondback rattlesnake (Crotalus adamanteus) have all been used as 
defibrinogenating agents for several clinical conditions including deep vein thrombosis, myocardial 
infarction, pulmonary embolus, and many others 72. Venoms with anticoagulant properties are extensively 
studied for possible medical applications. The drug Aggrastat (tirobifan) was developed from a compound 
in the venom of the saw-scaled viper (Echis carinatus), and is used as an anti-platelet drug (glycoprotein 
IIb/IIIa inhibitors) 73 and given to those with unstable angina (Fig. 4). Many venoms with procoagulant 
properties find application in the diagnosis of  clotting abnormalities, and most of the clotting pathways 
can be assayed by some venom component.  For example “Reptilase time” (B. atrox) assays for thrombin 
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inhibitors 74, “Ecarin” (E. carinatus) and “taipan time” (O. scutellatus) assays for phrothrombin, and 
Russell’s viper (Daboia russelii) venom assays for factor X and for monitoring anticoagulant therapy 75.  
 
Figure 4 |  Mechanisms of action of the anticoagulant Aggrastat developed from a compound in the venom of the Indian saw-
scaled viper (Echis carinatus). A: aggregated platelets by formation of fibrinogen bridges between the glycoprotein IIb/IIIa 
receptors. B: glycoprotein IIB / IIIA receptor antagonists like Aggrastat prevent platelet aggregation, and are mainly used in 
patients with acute coronary syndromes. 
A number of snake venoms create a transient condition of depressed blood pressure in 
envenomed patients. ACE-inhibitors were developed from a bradykinin potentiating enzyme isolated 
from the venom of the Brazilian pitviper (Bothrops jararaca) and approved in 1979 by the FDA 76 to treat 
high-blood pressure and heart disease (Fig. 5). They work by blocking the switch between angiotensin-I 
and angiotensin-II, the latter being a vasoconstrictor. These inhibitors are now prescribed worldwide and 
have saved the lives of millions.  
Many venoms have analgesic properties. Hannalgesin, derived from the venom of the king cobra 
(Ophiophagus hannah, see Fig. 2b)  is already in clinical trials 77. Promising toxins have been isolated 
from the tropical rattlesnake (Crotalus durissuss terrificus) and some other related species. Compounds 
derived from the Asiatic cobra (Naja kaouthia) are already in use in alternative medicine.  Being more 
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powerful than morphine, cobra venom was used in the 1930’s for treating intractable pain in cancer 
sufferers.   
There is great deal of research currently been done into the anti-cancer properties of venoms. For 
example malignant brain and spinal-cord tumors (gliomas) are not curable by surgery because they invade 
the surrounding brain tissue without clear boundaries, making removal impossible. Disintegrins, like 
contortrostatin from American copperhead (Agkistrodon contortrix) venom, prevent cells from sticking 
together, and inhibit their interaction with surrounding tissue and result in a blockage of cell motility and 
invasiveness 78. 
It has been demonstrated that fibrin(ogen) plays separate and distinctive roles at different stages 
of tumor growth and dissemination. At the primary site, fibrin deposition around the tumor could form a 
protective barrier, but also limit tumor progression. On the other hand, fibrin deposits formed by 
metastatic tumor cells may help disseminating these tumor cells 79. Anticoagulants and the removal of 
fibrin could be an effective therapy. One of the earliest reports on the successful use of a venom 
defibrinogenating enzyme was that of Wood and Hilgard 80.                            
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Figure 5 | Mechanism of action of ACE inhibitors developed from a bradykinin potentiating enzyme isolated from the venom of 
the Brazilian pitviper (Bothrops jararaca) and approved in 1979 by the FDA [75] to treat high-blood pressure and heart disease. 
Angiotensin I causes vasoconstriction which raises the blood pressure. 
Many cobra venoms contain Cobra Venom Factor (CVF), that activates and depletes the 
mammalian immune-complement system 81. They are structural and functional analogues of the 
mammalian serum complement factor C3 82. CVF is used as a tool to study various aspects of the 
complement system and in this respect CVF is a uniquely useful venom component that has also been 
found useful as an immuno suppressant agent in tissue transplantation and in cancer therapy  83.   
       Many venoms have antibacterial properties. For example, Stiles et al 84 found 2 antibacterial 
bioactive L-amino acid oxidase components in King brown (Pseudechis australis) venom that were 70 
and 17.5 times more effective in-vitro than tetracycline, a drug of choice for Aeromonas infections. 
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Antibacterial and antiparasitic effects of the venom of the Marajó lancehead (Bothrops marajoensis) were 
shown to be caused by PLA2 and and L-amino acid oxidase toxins 85.  
       Antiviral activity has been demonstrated in several venoms, although no commercialization of any of 
these compounds has yet taken place. The venom of the tropical rattlesnake (Crotalus durissus terrificus) 
from Brazil has been shown to be active against the measles virus 86. The purified PLA2 venom 
neurotoxin “taipoxin” from the coastal taipan (Oxyuranus scutellatus), Nigexine from the African black 
necked cobra (Naja nigricolis) and a basic PLA2 from the Mozambique spitting cobra (Naja 
mossambica) have been shown to have potent anti-viral activities against HIV-1 virus 87.    
         Myasthenia gravis, a chronic autoimmune disorder affecting 2 out of every 100,000 people,  results 
in progressive skeletal muscle weakness with rapid fatigue and loss of strength. It primarily affects 
mastication, facial and swallowing muscles and in advanced cases, respiratory muscles. Autoimmune 
antibodies destroy acetylcholine receptor sites at the neuromuscular junctions preventing nerve impulses 
from reaching the muscles. A rapid, quantitative and sensitive radioimmunoassay using human 
acetylcholine receptor, affinity labeled with purified neurotoxin, alpha-bungaratoxin, from the venom of 
the Taiwan krait (Bungarus multicinctus) is used to diagnose the condition 88,89. Most venoms possessing 
alpha neurotoxins are potential candidates for this purpose.   
 
High-throughput screening to identify potential new medicines in venoms 
A major obstacle in exploring snake venom for new leads into drug discovery is the low amount of 
venom usually obtained during the process of milking (extracting venom from the venom glands of a live 
snake, see Fig. 2c). In addition, it is difficult to extract venom from many of the “colubrid” snakes. 
Because of this, venom research has focused mainly on those snakes that are dangerous to humans, but 
this doesn’t necessarily reflect the potential of their venom for drug discovery. Some of the harmless 
“colubrid” venom toxins have been shown to be as potent as those of some deadly elapids, only produced 
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in small amounts 4,90. For example, the venoms of the Patagonia green racer (Phildryas patagoniensis)  
and Lichtenstein’s green racer (P. olfersii) have been shown to posses high proteolytic activity, degrading 
fibrinogen and the vascular wall 91, and strong edematogenic and myotoxic activity 92, respectively. In 
addition, a completely new family of toxins has recently been found in the venom of the Asian dog-faced 
water snake (Cerberus rynchops). These toxins, called veficolins, may induce platelet aggregation and/or 
initiate complement activation 93. Hence, the bias towards deadly snakes in exploring venoms for drug 
discovery is completely unwarranted.  
Alternatively with the use of molecular tools the venom gland transcriptome can be complied. 
This approach not only allows us to understand the expression profile and the evolution of the venom 
proteins 94, but also reveals the lowly expressed proteins which will expand our resource for 
pharmaceutically active molecules.        
Many of the medically significant venomous snakes produce hundred to a couple hundred 
milligrams of dry venom in a single milking 95.  Large species of elapids and viperids may produce from 
several hundred mg’s up to more than a gram of venom in a single milking 95. The recently described 
giant spitting cobra (Naja ashei) has been shown to produce the immense amount of 3 gm’s of weight of 
dry venom 96, the largest amount ever collected during a single milking. The amount of venom that a 
snake produces during milking is determined by the species, its geographic origin, its body size and 
relative head size, and by the time of the year that it is milked, as well as by interactions among these 
factors, body size being the primary factor 97.  
When biomedical researchers are looking for lead therapeutic agents against diseases, they can 
first look at those venoms of which the snakebite symptoms involve the same pathways as the disease, for 
example, using venom that causes vasodilatation to look for potential blood pressure regulators. However, 
snake venom is very complex and contains many different isoforms, some of which may only be present 
in very low quantities in the venom. For example, nerve growth factor is only present in a concentration 
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of about 0.1-0.5% 98. A fraction that stimulates neurite outgrowth was first identified in tumour cell 
extracts, but venom from cottonmouth vipers (Agkistrodon piscivorus), was then found to be up to 6,000 
times more potent 99 – a discovery that allowed the authors to study mechanisms which regulate cell and 
organ growth and for which they were awarded the Nobel prize in 1986. The problem is that venom 
compounds that are present only in low concentrations don’t necessarily contribute to the bite 
symptomology and may thus be easily overlooked, although they can be of high potential biomedical 
interest. To exploit the full potential of snake venoms, a wide variety of them need to be fractionated and 
all fractions tested separately in a high-throughput screen of interest. Mice have typically been used as 
model organisms, in for example identifying genes involved in pain and anxiety, and in screening for 
analgesic peptides 100. However, using mice is ethically controversial and low-throughput, screens also 
require relatively large amounts of the precious venoms. Zebrafish (Danio rerio) are now more and more 
used as model organisms to screen for new drugs, and this provides a significant window of opportunity 
for using snake venom (or venom from other venomous animals) to screen. Zebrafish are cheaper to 
maintain than rodents, their eggs and embryos are transparent so phenotypic changes can be visualized, 
and they can be easily scaled up into high-throughput assays 101 that require minimal amounts of venom,  
and automated imaging and analysis systems are available 102,103. Morpholino knockdowns can be 
performed by injecting the yolk sac of embryos, allowing live imaging studies, and many disease-related 
genes identified in humans have orthologs in zebrafish 101. Although zebrafish will never replace 
mammalian models completely in the drug development pipeline, they do form a cost-effective bridge 
between cell-based models on the one hand and rodent whole-organism models on the other 101.  
Conservation of snakes  
A recent report by conservation biologists 104 documented a disturbing trend - a global decline in non-
related snake species over the world during the same time period. Although they only looked at a small 
number of snakes (17 populations of eight species), we need to keep in mind that any species of snake 
that goes extinct may have held a new drug in its venom. Species having small home ranges, sedentary 
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habits and ambush feeding strategies are likely to be the most vulnerable as they rely on sites with 
specific types of ground cover that are disrupted by anthropogenic activities, and as ambush foraging is 
associated with a suite of life-history traits that involve low rates of feeding, growth and reproduction 105.  
 Current research on snake venoms is phylogenetically biased. Of the 1622 snake venom toxin 
sequences available on Universal Protein Resource database, only 49 are sequenced from snakes that do 
not possess any danger to humans. But with the high-throughput systems currently being developed this 
may hopefully soon change.  
 Very little data actually exist on the true conservation status of snakes worldwide. Out of 2711 
extant caenophidian species, 26 are CITES listed, i.e. less than 1%, while 967 are listed on the IUCN Red 
List of Threatened Species, i.e. 36%. The main causes identified for their threatened status are caused by 
humans: annual & perennial non-timber crops (272 sp.), logging & wood harvesting (179 sp.), housing & 
urban areas (143 sp.), livestock farming & ranching (98 sp.), hunting & trapping (64 sp.) and natural 
system modifications (57 sp.). Although the majority of the species listed have been categorized as Least 
Concern (60%), this does not necessarily reflect their true status 104, and for another 22% of the species 
the data are insufficient to categorize them accordingly. In addition, 87% of the species (837) have been 
added to the Red List since 2007, highlighting the lack of proper attention in the years before.  
If biogeography is considered, relatively well protected regions are North America (123 red listed 
sp.), Meso America (325 sp.), the Philippines (84 sp.) and Europe (29 sp.). On the other hand, several 
biodiversity hotspots such as South America (113 sp.), Sub-Saharan Africa (82 sp.), and the Caribbean 
Islands (16 sp.), among others are neglected while these areas may represent the locations with the highest 
potential for discovering snake species new to science, each representing new potential for advancing the 
frontiers of clinical medicine. 
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Conclusions and future perspectives 
While the use of snake venom for medicinal purposes dates back to ancient times, the past few decades 
have seen several new drugs derived from components of snake venom becoming available to patients 
worldwide. Here, we have reviewed recent advances in areas ranging from evolutionary to molecular 
biology that taken altogether indicate new possibilities for contributions to clinical medicine and medical 
research from snake venom. First, advances in snake systematics demonstrate a high degree of 
phylogenetic bias in previous molecular prospecting in snake venom, increasing the number of species 
from which medically useful molecules may be obtained. Secondly, discoveries in snake venom 
composition have revealed an unexpectedly high degree of variation of snake venoms of the same species 
linked to variables such as diet, geographical distribution, ontogeny and others. These two factors 
increase the potential pool that snake venom represents for pharmacological prospecting. Finally, new and 
innovative techniques in high throughput systems offer increased speed and efficiency in identifying and 
extracting desirable molecules from snake venom. In conclusion, we emphasize the challenges faced by 
the conservation of snake biodiversity, since it is ultimately on this that hopes for the development of new 
therapeutic agents from snake venom depends. 
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Many advanced snakes use fangs — specialised teeth associated with a venom gland 
106-108
 — to 
introduce venom during prey capture or defence. Various front- and rear-fanged groups are 
recognised, according to whether fangs are positioned anterior (e.g. cobras and vipers) or posterior 
(e.g. grass snakes) in the upper jaw 
109-111
 . A fundamental controversy in snake evolution is whether 
or not front and rear fangs share the same evolutionary and developmental origin 
107,109-114
.  Solving 
this controversy would point to a major evolutionary transition that underlies the massive radiation 
of advanced snakes, and to the underlying developmental events. We examine this issue by 
visualising the tooth-forming epithelium in the upper jaw of 96 snake embryos, covering eight 
species. We use the sonic hedgehog (shh) gene as a marker 
115-118
, and reconstruct the development 
in 3D in 41 of these. Here we show that front fangs develop from the posterior end of the upper jaw, 
and we reveal a striking similarity in morphogenesis between front and rear fangs that argue for 
their homology. In front-fanged snakes, the anterior part of the upper jaw lacks shh expression, 
and ontogenetic allometry displaces the fang from its posterior developmental origin to its adult 
front position — suggesting a posterior evolutionary origin. In rear-fanged snakes, the fangs 
develop from an independent posterior dental lamina and retain their posterior position. In light of 
our findings, we suggest a possible new model for the evolution of snake fangs; a posterior sub-
region of the tooth-forming epithelium became developmentally uncoupled from the remaining 
dentition. This would have allowed the posterior teeth to evolve independently and in close 
association with the venom gland, becoming highly modified in different lineages. This 
developmental event could have facilitated the massive radiation of advanced snakes in the 
Cenozoic era, resulting in the spectacular diversity of snakes seen today 
5,107,119
. 
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Many advanced snakes (Caenophidia, sensu ref. 22) use venom, with or without constriction, to subdue 
their prey 5,107. Their venom-delivery system includes a post-orbital venom gland associated with 
specialised venom-conducting fangs108. Fangs can occupy various positions on the upper jaw, but are 
always located on the maxilla and never on any other tooth-bearing bone 120  (Fig. 6C). Viperidae (vipers 
& pitvipers), Atractaspis (Lamprophiidae, sensu ref. 22), and Elapidae (cobras and relatives) have tubular 
front fangs  (Fig. 6B,C). The remaining lineages are all non-front-fanged and called either ‘non-fanged’ 
(no distinguishable enlarged posterior tooth) or rear-fanged 107,120  (Fig. 6B,C). Rear fangs can be solid, 
slightly or deeply grooved, but never tubular 120.  
There has been active debate concerning the evolutionary origin of these different fang types, and 
their relationships to the simple, unmodified teeth of non-fanged 121 basal snakes 107,109-114,121 such as 
pythons and boas (Boidae). Proposed hypotheses include: (i) front-fanged snakes form a monophyletic 
group and their fangs are derived from rear-fangs 113,122,123 ; (ii) elapid fangs are derived from front teeth 
and viperid fangs from rear fangs 124,125 ; (iii) elapid and viperid fangs are both derived from rear-fangs 112 
; and (iv) front and rear fangs have independent origins 107. Establishing the origin and evolutionary 
transformation series between these dentition types requires a robust phylogeny to map the characters 
onto. Since recent molecular phylogenies of caenophidians place the front-fanged Viperidae as relatively 
basal and the front-fanged Elapidae as more recently derived 1,107 (Fig. 6A), the current evidence seems to 
support the ‘independent-origin’ hypothesis 107. 
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Figure 6 | Adult maxillary dentition mapped onto a molecular snake phylogeny to show relative positions of the various fang 
types. a, Phylogeny from ref. 16. b, c, Adult skulls (Supplementary Table 4): lateral views (b); palate, schematic ventral views (c; 
maxilla coloured, fangs circled). Asterisks indicate species studied by electron microscopy (Supplementary Fig. 5, 
Supplementary Table 3). The evolutionary changes leading from an unmodified maxillary dentition to the different fang types in 
advanced snakes are indicated at the nodes: (1) continuous maxillary dental lamina, no specialized subregions—ancestral 
condition for advanced snakes; (2) evolution of posterior maxillary dental lamina—developmental uncoupling of posterior from 
anterior teeth; (3) starting differentiation of the posterior teeth with the venom gland; (4) loss of anterior dental lamina and 
development of front fangs. 
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 To date, this issue has not been examined using a molecular developmental approach, not least 
because of the difficulty of obtaining snake embryos of all the different species. Development of fangs 
and venom glands has been studied before in viperids 126,127,  Natrix 128,129  (Natricidae), Spalerosophis 130, 
Thamnophis and Telescopus 106,108  (Colubridae). Those morphological studies identified a common 
primordium of the venom gland and fangs 106,126,128, but did not visualise the odontogenic band (tooth-
forming epithelium: a band of epithelial tissue that invaginates and forms a dental lamina). Therefore, no 
conclusions could be drawn about the origin and evolutionary transformation series of the fangs.  
Here, we have carried out in situ hybridisation of the sonic hedgehog (shh) gene in 96 snake 
embryos of multiple stages, and reconstructed the development of the maxillary dentition in 3D in 41 of 
these through serial sections. We use nine advanced snake species — comprising two front-, one rear- and 
one ‘non-fanged’ lineage. As outgroup we included the non-fanged waterpython (Liasis mackloti: 
Boidea), which is basal to advanced snakes (Fig. 6). Shh is expressed in the odontogenic band in different 
vertebrate species 115-117.  By visualising this band, we aim to find evidence for the ancestral condition of 
the maxillary dentition.  A list of all material studied can be found in Supplementary Tables 1-4. We map 
our characters onto the recently published, robust molecular phylogeny of advanced snakes obtained by 
Vidal et. al. 2007 (ref. 22, and Fig. 6A).  
In the waterpython (L. mackloti), shh expression reveals one continuous maxillary odontogenic 
band (Fig. 7a). As confirmed by serial sections of embryos ranging from young to old, this band 
invaginates to form one dental lamina — a single continuous, invaginating epithelium that will develop a 
row of teeth (Fig. 8a & Fig. 9j-l). This is consistent with a recent morphological study of Python sebae 131. 
The odontogenic band, with its associated lamina, appears along the entire rostrocaudal extent of the 
upper jaw — from the premaxilla to the mandibular articulation (Fig. 7a). This suggests that the ancestral 
condition for the maxillary dentition of advanced snakes is one dental lamina that appears along the entire 
rostrocaudal extent of the upper jaw, lacking specialised sub-regions.  
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The early odontogenic band in the non-front-fanged grass snake Natrix natrix (Natricidae) and rat 
snake Elaphe obsoleta (Colubridae) is similar to that of the waterpython (Fig. 7c & Suppl. Fig. 2f,i) 
However, we show for the first time that there are two dental laminae which invaginate separately (Fig. 
8b,e & Fig. 9a-c & Suppl. Fig. 8e-g) and fuse during development (Fig. 9c & Suppl. Fig. 3h-i). The 
anterior lamina bears only teeth (Fig. 9c & Suppl. Fig. 3f) and is similar in development to the one in the 
waterpython (Fig. 9j,k&l). The posterior lamina, however, bears teeth and forms the common primordium 
with a post-orbital gland (Fig. 8b & Fig. 9b-c & Suppl. Fig. 3i). These develop into the rear fangs and 
venom gland in the grass snake, and probably represent the first differentiation of the posterior teeth with 
a venom gland in the rat snake. The latter observation is consistent with a recent MRI and histology study 
132, showing the presence of a small gland in rat snakes. To verify that the anterior and posterior dental 
laminae are truly developmentally independent, we ablated the primordium of the anterior lamina in 
isolated developing upper jaws of the dice snake Natrix tessellate 133 (Suppl. Fig. 3m-o) 134. After 
cultivation under the yolk sac membrane, we found that the posterior lamina, with its venom gland 
and fangs, developed normally in the absence of the anterior lamina (Suppl. Fig. 4), showing that they are 
developmentally independent. 
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Figure 7 | Shh expression in the embryonic snake palate, showing the posterior developmental origins of front fangs. a–d, Palate, 
ventral view: top, anterior; scale bar, 0.5 mm; dotted lines, upper jaw (posterior margin of premaxilla to attachment of the 
mandible); boxes, schemes of maxillary odontogenic band (purple, shh expression; grey, no shh expression). Positions of fangs in 
b–d were identified histologically (Fig. 3, Supplementary Fig. 3). The odontogenic band in the front-fanged species is located 
posterior in the upper jaw (b, d). In the non-fanged outgroup (a) and the rear-fanged Natrix (c), the odontogenic band extends 
along the entire upper jaw. f, fang; mx, maxillary odontogenic band; pa, palatine odontogenic band; pt, pterygoid odontogenic 
band. e, Ontogenetic allometry in the fang in the front-fanged Causus displaces the fang along the upper jaw (Supplementary 
Figs 5–9, Supplementary Tables 5–9). Scale bars, 1 mm. We note the change in relative size of the upper jaw subregions: i, 
anterior; ii, fang; iii, posterior. d.a.o., days after oviposition.  
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Figure 8 | Sections of the shh in situ hybridizations of the embryonic upper jaw in five snake species, showing the posterior and 
anterior dental laminae. a–c, e–f, Sagittal sections, anterior to the left, of L. mackloti (Boidae) 22 d.a.o. (a), N. natrix (Natricidae) 
22 d.a.o. (b), Calloselasma rhodostoma (Viperidae) 8 d.a.o. (c), N. natrix 22 d.a.o. (e), Naja siamensis (Elapidae) 23 d.a.o. (f). d, 
transverse section, medial to the left, of Trimeresurus hageni (Viperidae) 8 d.a.o. The posterior maxillary dental laminae in b and 
e are similar in morphogenesis to the maxillary dental laminae in all front-fanged species examined (c, d, f; see also Fig. 4). 
Arrowheads, shh expression; amdl, anterior maxillary dental lamina; dr, dental ridge; e, eye; f, fang; mdl, maxillary dental 
lamina; pa, palatine dental lamina; pmdl, posterior maxillary dental lamina; t, tooth bud; vd, primordium of venom gland; scale 
bars, 300 mm. 
In the five front-fanged species examined (Viperidae and Elapidae), the maxillary odontogenic 
band is found in the posterior part of the upper jaw (Fig. 7b,d & Suppl. Fig. 2a,d,g). There is no shh 
expression nor dental lamina in the anterior region (verified by histology, data not shown). By contrast, in 
the waterpython, grass and  rat snake, the odontogenic band and associated dental laminae appear along 
the entire rostrocaudal extent of the upper jaw. We find that, during development, the ‘rear’ fang is 
displaced to its adult ‘front’ position by ontogenetic allometry (Suppl. Figs. 6 & 7 and Suppl. Table 6 for 
statistical analyses); suggesting a posterior evolutionary origin of the front fangs. Histology shows that 
although the odontogenic band invaginates normally and forms one dental lamina (in contrast to the non-
front-fanged snakes examined above), in all front-fanged species the fangs develop from the 
posteriormost part of this lamina and there are no developing teeth in the anterior part (Fig 8f & Fig. 9d-
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h). This apparently toothless part of the dental lamina has been described before only in Vipera aspis 
(Viperidae) and termed the ‘dental ridge’ 128.  We show it here for the first time in Elapidae (Fig. 8f & 
Suppl. Fig. 3j-l). The fact that viperids and elapids share; (i) the ‘dental ridge’ and (ii) a posterior 
developmental origin for their front fangs is interesting, since they are phylogenetically not closely related 
(Fig. 6A).  
 
 
 
 
 
 
 
Figure 9 | (page 34) Schematic three-dimensional reconstructions showing the similarity in morphogenesis between the rear and 
front fangs. Derived from serial sections (Fig. 8, Supplementary Fig. 3); materials analysed are listed in Supplementary Tables 1, 
2, 4. Left-hand side of the upper jaw is depicted, and only epithelial components are shown. Purple, shh expression; grey, tooth 
buds; green, unspecialized maxillary dental lamina; orange, specialized maxillary dental lamina that bears fangs. The specialized 
dental lamina is dilated into a bifurcated epithelial sac, the lateral part giving rise to the venom duct and venom gland by growing 
rostrad (see also Fig. 3b–d, f), then turning caudad to reach the post-orbital region (as previously described for vipers 126,127, 
Natrix 128,129 and Spalerosophis 130. In Elaphe obsoleta (a–c) and Natrix natrix (data not shown), fangs develop rostrally and 
caudally alongside the base of the venom duct; in Naja siamensis (d–f) and Trimeresurus hageni (g–i) the rostral part regresses, 
remaining visible only as the dental ridge, whereas in b and c this part bears fangs and fuses with the anterior dental lamina. The 
unspecialized dental lamina in E. obsoleta (a–c) and the outgroup Liasis mackloti (j–l) starts developing anterior and grows 
caudad. 
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Because Elapidae and Viperidae do not form a monophyletic group (Fig. 1A), the ‘dental ridge’, 
the posterior developmental origin of the fangs, and the allometric growth in both lineages may still 
reflect convergent evolution. However, our 3D reconstructions reveal that there is a striking similarity in 
morphogenesis of all front and rear fangs examined  (Fig. 9b-i), despite the large variation in adult 
morphology. The toothless ‘dental ridge’ seen in elapids and viperids is similar to the part of the posterior 
dental lamina that fuses with the anterior dental lamina in the grass snake and the rat snake (Fig. 9). 
Although developmental similarity is not conclusive proof of structural homology, this is especially 
interesting in light of the posterior developmental origin of the front fangs in both elapids and viperids 
mentioned above. These results are difficult to reconcile with the ‘independent-origin’ hypothesis, but are 
consistent with the hypothesis that elapid and viperid front fangs, and the posterior dental lamina in non-
front-fanged snakes, represent homologous structures.  
Our results suggest a possible model for the evolution of snake fangs. A posterior sub-region of 
the ancestral tooth-forming epithelium became developmentally uncoupled from the remaining dentition, 
resulting in a posterior and anterior dental lamina that are developmentally independent (Suppl. Fig. 1). 
This condition is retained in the non-front-fanged snakes, such as the grass and rat snake. This model 
would imply that the front-fanged elapids and viperids have independently and secondarily lost the 
anterior dental lamina (Fig. 6), which is supported by the lack of shh expression anterior in their upper 
jaws.   
Since obtaining developmental data for each non-front-fanged advanced snake lineage is 
impracticable, convergence cannot be ruled out completely.  We have, therefore, examined the adult 
maxillary tooth morphologies through scanning electron microscopy in the waterpython, the grass and rat 
snake, and a further wide range of non-front-fanged advanced snake species (Fig. 6A). We aimed to find 
differences in the maxillary dentition, which might suggest the presence of two maxillary dental laminae 
in additional lineages. Our results show, indeed, that there is a consistent difference in anterior versus 
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posterior tooth morphologies in additional advanced snake lineages (Suppl. Fig. 5d-x, and Suppl. Table 
3). In contrast, the maxillary teeth from the Boidae do not show a morphological difference between 
anterior and posterior teeth (Suppl. Fig. 5f). These results suggest the possible presence of two dental 
laminae in other non-front-fanged advanced snake lineages, and provides additional support to our 
proposed model.  
The developmental uncoupling of the posterior from the anterior tooth region represents a 
possible mechanism that could have allowed the posterior teeth to evolve independently and in close 
association with the venom gland. Subsequently, it could became modified and form the fang-gland 
complex — an event which underlies the massive radiation of advanced snakes during the Cenozoic era 
107,119,132. 
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Methods  
Snake embryos. Snake eggs and embryos were acquired in accordance with local and international 
regulations from European and Australian breeders and zoos. Eggs were incubated at 30°C and embryos 
fixed in 4% paraformaldehyde in PBS at 4°C overnight. They were dehydrated through graded methanols 
and stored at -18°C.  
In situ hybridization. The RNA probe is based on the partial PCR product of SHH using the cDNA of a 
1-day-old Rhombic Night Adder (Causus rhombeatus) embryo as template (GeneBank accession number 
EU236145). Hybridization was performed according to standard protocols. In all species examined, the 
odontogenic band (tooth-forming epithelium) always expressed shh (Fig. 2 & Suppl. Fig 2). This shows 
that, as in other vertebrate groups 115-117, shh is also a marker for odontogenic epithelium in snakes. A list 
of embryos studied can be found in Suppl. Table. 1.  
Histology. Embryos where dehydrated through ethanols or methanols, cleared in HistoClear or 
tetrahydronaphthalene, and embedded in paraffin.  Sections were cut at 5-7 microns and counterstained 
using Neutral Red or H+E. A list of embryos studied can be found in Suppl. Table. 2. 
3D modeling. Schematic 3D models were drawn from analyses of the serial sections of the embryos 
using a Nikon Eclipse E800 microscope. All models were drawn using Adobe Illustrator and Adobe 
Photoshop.  
Scanning electron microscopy. The maxillary bone on one side was dissected out of the specimen, 
allowed to dry and mounted on a stub, using double-sided tape, with teeth pointing upwards. Specimens 
were sputter-coated with gold, and examined using a JEOL JSM-T300 scanning electron microscope, at 
an acceleration voltage of 15kV. A list of specimens examined with their museum numbers can be found 
in Suppl. Table. 3. 
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Ablation experiment. Was performed as previously described 133.  
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Chapter 4: Axial Patterning in Snakes and Caecilians: Evidence for an Alternative 
Interpretation of the Hox Code 
 
Woltering JM, Vonk FJ, Müller H, Bardine N, Tuduce IL, de Bakker MA, Knöchel W, Sirbu IO, 
Durston AJ and MK Richardson. 
 
This chapter has been published in Dev Biol 332, 82-89 (2009).  
Supplementary Material can be found here: http://bit.ly/HVisC0  
 
Part of this chapter has been published in: 
Vonk FJ & Richardson MK.  Serpent clocks tick faster. Nature 17, 282-3 (2008). 
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It is generally assumed that the characteristic deregionalized body plan of species with a snake-like 
morphology evolved through a corresponding homogenization of Hox gene expression domains 
along the primary axis. Here, we examine the expression of Hox genes in snake embryos and show 
that a collinear pattern of Hox expression is retained within the paraxial mesoderm of the trunk. 
Genes expressed at the anterior and most posterior, regionalized, parts of the skeleton correspond 
to the expected anatomical boundaries. Unexpectedly however, also the dorsal (thoracic), 
homogenous rib-bearing region of trunk, is regionalized by unconventional gradual anterior limits 
of Hox expression that are not obviously reflected in the skeletal anatomy. In the lateral plate 
mesoderm we also detect regionalized Hox expression yet the forelimb marker Tbx5 is not 
restricted to a rudimentary forelimb domain but is expressed throughout the entire flank region. 
Analysis of several Hox genes in a caecilian amphibian, which convergently evolved a 
deregionalized body plan, reveals a similar global collinear pattern of Hox expression. The 
differential expression of posterior, vertebra-modifying or even rib-suppressing Hox genes within 
the dorsal region is inconsistent with the homogeneity in vertebral identity. Our results suggest that 
the evolution of a deregionalized, snake-like body involved not only alterations in Hox gene cis-
regulation but also a different downstream interpretation of the Hox code. 
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The patterning and morphogenesis of the vertebrate skeleton during embryonic development is regulated 
by Hox genes. In tetrapods, the Hox gene family consists of 39 closely related homeobox genes consisting 
of 13 paralogous gene groups organized in 4 clusters (named A, B, C and D) (reviewed in 135. These 
genes are expressed in collinear spatial domains along the antero-posterior body axis and act as effectors 
of vertebral identity. The sequential expression pattern of different Hox genes is often referred to as “the 
Hox code” 136 which, combined with different inductive properties of the genes, provides positional 
information for the antero-posterior regionalization of the axial skeleton. Typically, Hox genes form 
nested expression series and the domains of anterior genes overlap with those of more posterior genes. 
Where several genes are co-expressed, posterior genes act dominantly over anterior genes, a form of 
phenotypic suppression called “posterior prevalence” 137. The evolutionary conservation of the Hox 
patterning system is reflected in the fact that expression boundaries of Hox genes correlate with the same 
anatomical transitions in different vertebrate species 138,139 and changes in Hox expression are often 
suggested to underlie macro-evolutionary modifications of the bodyplan140.  
Evolution has produced an astonishing diversity of body shapes adapted to different lifestyles. An 
important contributor to the shape of animals with backbones is the number of bones (vertebrae) that 
make up this structure. Some animals have gone to extremes (Fig. 10), none more so than snakes, which 
have more vertebrae than any other living animal — often more than 300, with some species  having more 
than 500. One of the most striking modifications of the vertebrate axial skeleton is the evolution of a 
‘snake-like’, elongated body plan as adopted by at least 7 extant taxa of reptiles, fish and amphibians 
independently141 (Fig. 10).  The evolutionary transition to a snake-like body plan is accompanied by a 
profound deregionalization of the axial skeleton which includes loss or reduction of the limbs and limb 
girdles, as well as sternal elements 141,142. These species have a greatly increased number of 
vertebrae141,143,144  and, with the exception of the atlas, all of the pre-cloacal vertebrae are usually rib 
bearing. In contrast to non-elongated species, the dorsal (in squamates the rib-bearing region of the trunk 
skeleton is termed ‘dorsal’ instead of ‘thoracic’) region of the skeleton is extremely homogeneous with 
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few or no differences between ribs and vertebrae along the antero-posterior axis. It has been hypothesized 
that this peculiar “deregionalized” limbless anatomy results from a corresponding homogenization of Hox 
expression domains along the snake’s primary axis145. In this study we set out to analyse Hox expression 
in detail, including previously unexamined posterior paralog members in the corn snake (Pantherophis 
guttatus) and to a lesser extent, because of material scarcity, in a caecilian amphibian (Ichthyophis cf. 
kohtaoensis), which evolved a comparable body plan independently. 
 
Figure 10 | Body elongation, including increased numbers of vertebrae and a longer backbone, has evolved independently many 
times among vertebrates. a, Eastern glass lizard (Ophisaurus ventralis). b, European eel (Anguilla anguilla). c, Sao Tome 
caecilian ((Schistometopum thomense). d, Malayan pit viper (Calloselasma rhodostoma). Photos not to scale. (a,b,d, F.J.V. & 
M.K.R.; c, S. Blair Hedges.) 
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Results 
Spatially collinear Hox expression in the snake somitic mesoderm 
 
The axial skeleton of the corn snake consists of a total of 308 vertebrae (Fig. 11) and the anatomical 
subdivisions are listed in Table 1. Characteristic features include the complete absence of limb girdles, 
sternal elements, forelimbs and hindlimbs and the presence of homogeneous ribs on all but the 3 most 
anterior pre-cloacal vertebrae. 
 
 
Figure 11 | Alcian blue staining of an advanced corn snake embryo to show the skeletal anatomy. The axiak skeleton consists of 
308 vertebrae; the atlas (At), the axis (Ax), 1 additional cervical vertebrae (C3) and 231 dorsal vertebrae (D), 4 cloacal vertebrae 
(CL) and 70 caudal vertebrae (CD). The first doral, cloacal and caudal vertebrae are indicated. SB; skull bone, H; hyoid.  
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We examined the expression of a panel of Hox genes in tailbud stage embryos (see 
Supplementary Material, Fig. S1). For all Hox genes examined, we observe, as reported previously145, a 
strong homogenous expression in the posterior part of the trunk, but also a clear spatially collinear 
expression in the anterior part of their expression domains (Fig. 12 A-T and Table 1).  
Table 1 | Corn snake axial formula and anterior somitic Hox expression limits 
Indicated here are the vertebral types, their position and number, and whether they are rib-bearing, the lymphapophyses of the 
snake cloacal vertebrae are indicated as forked ribs. Anterior somatic Hox expression boundaries are given below. Where Hox 
expression boundaries coincide with an anatomical transition this is indicated. A pre-vertebrae range is given in case of a diffuse 
expression limit.  
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The anterior expression boundaries of the most anterior and most posterior Hox genes examined, 
HoxA3, HoxB4 and HoxC13, coincide with homologous morphological boundaries in the mouse and 
chicken 4, 12 (Fig. 12 A, B, S, T and Table 1). They are located at the atlas, axis and cloaca respectively 
and are thus expressed at expected positions within regionalized parts of the snake trunk. 
 
Figure 12  | Hox gene expression in corn snake embryos. All embryos are at the second day after oviposition. Hox gene names 
are indicated in the upper right corner of each picture. (A-E,J,K). Expression of HoxA3, HoxB4, HoxC5, HoxA6, HoxB6, HoxB7 
and HoxB8. These anterior genes have sharp anterior expression boundaries in the somitic mesoderm indicated with a black 
arrowhead and a number referring to the pre-vertebra level. Red arrowheads indicate the anterior expression boundaries in the 
lateral plate mesoderm and blue arrowheads indicate the anterior limit of expression in the neural tissue. In some panels an 
example of spinal ganglion expression is indicated with a green arrowhead. For these Hox genes additional expression data is 
provided in the supplementary data (Fig.S2). (F-I, L-O) Expression of HoxC6, HoxA7, HoxC8 and HoxB9. These anterior genes 
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have gradual anterior expression limits in the somitic mesoderm which are difficult to visualize exactly in the whole mount views 
(F,H,L,N,O). In these whole mounts a black asterisk is placed in the anterior somitic domain where no expression is detected and 
a white asterisk is placed in the posterior domain where the genes are expressed robustly. The expression limits for these genes 
are indicated more precisely in flat mounts of the anterior trunk region (G,H,M,O). In these images anterior expression limits in 
the somitic mesoderm are indicated with a black arrowhead and a number indicating the pre-vertebra level. This somitic domain 
is indicated again more posteriorly in a region of more robust expression with a white arrowhead and the indication of pre-
vertebra level. In some panels an example of spinal ganglion expression is indicated with a green arrowhead and the anterior start 
of the neural expression domain is indicated with a blue arrowhead. For these Hox genes additional expression data is provided in 
the supplementary material (Fig.S3-6). (P-Q) HoxC10 expression in whole mount (p) and flatmount of trunk/tail transition (Q). 
HoxC10 is expressed in the somotic mesoderm anterior to the cloaca (indicated “C”) and cloacal vertebrae (indicated with black 
arrowheads and “CL”) anterior to approximately pre-vertebra 200 (indicated with a black arrowhead and number) in a region of 
the trunk that will give rise to rib bearing vertebrae. Expression in pronephric vesicles is indicated with a black arrowhead and 
“P”. Additional HoxC10 expression data is provided in the supplementary material (Fig.S7). (R,S) Expression of HoxC13 in 
whole mount (R) and flat mount of trunk/tail transition (S).  HoxC13 is expressed in the somitic mesoderm up till approximately 
the cloaca (indicated “C”), expression indicated with a black arrowhead. The anterior limit of neural expression is indicated with 
a blue arrowhead.  
The dorsal region in snakes extends for most of the body length and has remarkable similar 
vertebrae. Despite this very poor regionalization, we do detect collinear expression in the dorsal region of 
the Hox genes belonging to paralogous groups 5-9. These genes are differentially expressed in the trunk 
and have been experimentally linked to the patterning of the thoracic and lumbar region in mouse and 
chicken 138,146-148 (Fig 12 C-O, Supplementary Material Fig S2, 3 and Table 1). The anterior boundaries of 
the most anteriorly expressed of these paralogous genes are sharply demarcated (HoxC5, HoxA6 and 
HoxB6) or decrease in intensity over several somites (HoxB7 and HoxB8). Genes expressed more 
posteriorly (HoxC6, HoxA7, HoxC8 and HoxB9) show unconventional gradual anterior limits of 
expression, slowly fading out over the course of approximately 10 somites, but being completely absent 
from the anterior part of the trunk paraxial mesoderm. We analyzed expression of several genes at earlier 
stages (~150 somites: HoxA6, HoxB6, HoxC6 and HoxB9; data not shown) or later stages (~ 5 days: 
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HoxC8 and HoxB9; data not shown) and detected expression in the same pattern as observed in the stages 
shown in Fig. 12.  
Snakes lack a lumbar region and rib-bearing vertebrae are present up to the cloaca. Genes from 
the Hox-10 group suppress thoracic and induce lumbar fate in the mouse and expression of these genes is 
normally absent in the thoracic mesoderm138,149-151. In the corn snake by contrast, we detect expression of 
HoxC10 within the rib-bearing part of the trunk (Fig. 12 Q, R, Fig. S4) and this expression thus conflicts 
with its presumed function as a rib suppressor (at least in snakes). As it has been suggested that Hox-10 
genes exert their rib suppressing activity in the pre-somitic mesoderm 150, we analyzed embryos at earlier 
stages and we also detected HoxC10 expression in the pre-somitic mesoderm of rib-bearing somites 
(Supplementary Material Fig. S4).  
Contrary to expectations, therefore, we find that the somitic mesoderm, which will give rise to the 
dorsal (thoracic) homogeneous rib-bearing part of the skeleton, is regionalized by Hox genes that are 
known to possess vertebra-modifying or even rib-suppressing activity in the mouse. Despite this 
regionalization, the dorsal skeleton shows no or very little regionalisation of vertebral anatomy. 
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Comparison of Hox expression at the cervico-dorsal transition in snake and lizard embryos 
 
Snakes have no well-defined transition from trunk to neck (cervico-dorsal) which in other squamates is 
marked by the position of the forelimb girdle (squamates often have rib-bearing vertebrae in the neck 
region hence presence of ribs is not a useful anatomical marker)140,142. The expression boundaries of 
HoxC5, HoxA6, HoxB6, HoxC6 and HoxB8 are located around the cervico-dorsal (thoracic) transition in 
mouse and chicken138,148,152,153  and expression of the three Hox-6 paralogs coincides at the level of 1st 
thoracic vertebra138,153. In the corn snake HoxA6 is expressed as far anterior as pre-vertebra 4, HoxB6 as 
far as pre-vertebra 3 while HoxC6 is expressed gradually up to approximately pre-vertebra 11 (Fig. 13 
and Supplementary Material Fig. S2). The expression of these genes thus seems shifted relative to each 
other, possibly in relation to the deregionalization of the snake body plan. However, due to lack of Hox 
expression data from non-snake squamates these differences in expression could also represent a 
synapomorphic squamate character. Therefore, we investigated the expression boundaries of hoxC5, 
HoxC6, HoxB6 and HoxB8 in the bearded dragon lizard (Pogona vitticeps) and of HoxA6 in the green 
anole lizard (Anolis carolinensis) (Fig. 14). These species have 4 rib-less neck vertebrae and the forelimbs 
are positioned between vertebra 6 and 7 (data not shown). HoxC5 and HoxB8 have anterior expression 
boundaries at the level of the 6th pre-vertebra, HoxA6 is expressed at the level of 5th pre-vertebra (the first 
rib-bearing vertebra), HoxC6 at the 7th pre-vertebra and HoxB6 at the 3rd pre-vertebra (Fig. 14 A-E). This 
shows that a relatively normal cervico-dorsal transition, although slightly elongated, is patterned in snakes 
(Fig. 14 F). Interestingly, the expression of HoxA6 corresponds to the transition from rib-bearing to rib-
less vertebrae at pre-vertebra level 4 in the snake and pre-vertebra 5 in the anole lizard. However, all the 
other skeletal anatomical features associated with this transition are absent in snakes. 
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Figure 13  | Schematic visualization of the approximate anterior mesodermal limits of Hox gene expression in the mouse and 
snake. Schematic drawing of a mouse and a snake skeleton, with indications of the approximate anterior boundaries of Hox gene 
expression, demonstrating a conservation of global collinear Hox expression zones in the snake despite absence of a 
correspondingly regionalized skeleton. Colours indicate the predominant anatomic region the genes are associated with. For 
precise levels of Hox expression zones in the snake, see Table 1, for the exact mouse expression data, refer to the cited literature. 
For the mouse, expression data from 138 were used for HoxB4, HoxC5, HoxC6 and HoxB7.   HoxA7 is according to 154, HoxA3 
according to139, HoxC13 according to155, HoxA6 according to153, HoxB6 according to152, HoxB8 and HoxC8 according to148, and 
HoxC10 according to151. The relative position of HoxB9 is mapped according to its expression at the lumbar/thoracic transition in 
chicken138. In the mouse HoxB9 expression appears however to be dynamically shifting along this axis, with at earlier stages 
more anterior and at later stages more posterior expression than indicated here 146,156. Genetically the Hox-9 genes have been 
demonstrated to be involved in the patterning of the thorax as well as the suppression of anterior thoracic fate in the lumbar 
region 146,156, therefore the gene is indicated in the mouse as being both thoracic and lumbar.  
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Conservation of global collinear Hox expression domains in a caecilian amphibian 
 
Caecilian amphibians have independently evolved a snake like postcranial skeleton. We analysed Hox 
gene expression in embryos from a caecilian (Ichthyophis cf. kohtaoensis) which has a skeleton consisting 
of 126 vertebrae with the atlas being the only pre-cloacal rib-less vertebra (Fig. 15, axial formula given in 
Table 2). We examined expression of HoxC5, HoxC6, HoxB8, HoxC8 and HoxC13 and analyzed their 
expression in Brauer stage 26 embryos (Supplementary Material Fig. S1). The global expression patterns 
of these genes are comparable to snakes and they exhibit spatially collinear expression within the trunk 
(Fig. 16, Supplementary Material Fig. S5 & Table 2). Similarly to snakes, the expression domains of 
HoxC5, HoxC6, HoxB8 and HoxC8 are not linked to morphology in the axial skeleton in the dorsal region 
and HoxC13 expression corresponds to the transition into the caudal region. 
 
Figure 14 | Hox gene expression in lizard embryos and comparison of snake and lizard cervico-dorsal transition Hox patterning. 
(A-E) Expression of HoxC6, HoxB6 and HoxB8 in embryos of bearded dragon lizard and HoxA6 in the green anole lizard. 
Expression in the somitic mesoderm is indicated with black arrowheads and numbers referring to the pre-vertebra levels. Anterior 
boundaries of neural expression are indicated with a blue arrowhead. Hox genes are indicated in the upper right corner of each 
image. In the panel for HoxB8 (D) an example of spinal ganglion expression is indicated with a green arrowhead. (f) Schematic 
visualization of Hox expression patterns in the cervico-dorsal transition in lizard and corn snake. The arrow indicates the position 
of the transition between cervical and dorsal region in the lizard. Despite the absence of most of the morphological skeletal 
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features corresponding to the cervico-dorsal transition, a regionalized pattern of Hox expression is preserved. Note that HoxA6 
expression corresponds to the start of the rib-bearing region in both snakes and lizards.  
 
Figure 15 | Alcian blue - Alazarin red staining of an advanced caecilian embryo to show the skeletal anatomy. The axial skeleton 
consists of 126 vertebrae, the atlas (At), 121 cervical / dorsal vertebrae and 5 caudal vertebrae. Each tenth vertebra is marked 
with an asterisk. C; cloaca.  
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Table 2 | Caecilian axial formula and anterior somitic Hox expression limits.  
In
dicating here are the vertebral types, their position and number, and whether they are rib-bearing. Anterior somitic Hox 
expression boundaries are given below. Where Hox expression boundaries coincide with an anatomical transition this is 
indicated.  
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Figure 16 | (page 52) Hox gene expression in Brauer stage 26 caecilian embryos. (A-E) Shown are flat mounted embryos with 
the yolk removed (for whole mount unprocessed example see Supplementary Material Fig. S1). Hox genes are indicated on the 
left. Anterior boundaries Hox gene expression in the somitic mesoderm is indicated with black arrowheads and pre-vertebrae 
levels are indicated with numbers. The anterior boundary of neural expression is indicated with a blue arrowhead and in the panel 
for HoxC8 (d) an example of spinal ganglia expression is indicated with a green arrowhead. (G) Close up of the tail plus posterior 
trunk region of HoxC13 expression, “C” indicates the position of the cloaca. (H-L) Fluorescent immune staining with the somite 
marker MF-20 antibody together with Hox gene in situ hybridization. In the brightfield close ups of head plus anterior trunk, the 
anterior Hox gene expression boundaries in the somites are indicated with black arrowheads and numbers indicating the pre-
vertebra level. In the fluorescent microscopy views of the same samples showing the somite specific staining of the MF-20 
antibody, the anterior level of Hox expression is marked with a white arrowhead and a white number referring to the somite 
number.   
Hox and Tbx5 expression in the snake lateral plate mesoderm 
 
In addition to the homogenous, extended rib cage, another typical feature of snake-like species is the lack 
of limbs. Hox genes are involved in limb bud induction and it has been shown that the forelimb buds 
develop at the anterior boundary of Hox-9 gene expression in the chick lateral plate mesoderm157. In the 
corn snake, we do observe collinear expression of HoxA, HoxB and HoxC genes within the lateral plate 
somatopleure (Fig. 12, Supplementary Material Fig. S2, 3 Fig. 16 A, D; lateral plate expression of all 
“thoracic genes” investigated, except HoxB4, HoxB6 and HoxA3, was verified by cryosectioning: 
Supplementary Material Fig. S2, 3 and data not shown). In general the axial level of Hox gene expression 
coincides or is located very near the axial level of the somitic boundary. For HoxC6 and HoxC8, which 
have very gradual anterior limits in the somites, we observe similar gradual anterior limits in the lateral 
plate (Supplementary Material Fig. S3 and data not shown).  
HoxB9 is expressed in the lateral plate mesoderm up to the same axial level as in the somitic 
mesoderm (Fig. 17 A, D). This position could thus correspond to a vestigial forelimb domain. We 
investigated the expression of the forelimb specific marker Tbx5 158,159 in the corn snake to see if any such 
domain could be detected at the molecular level. Unexpectedly however, Tbx5 is expressed throughout 
the entire antero-posterior extent of the somatopleure (Fig. 17 B, E and Supplementary Material Fig. S6). 
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Thus, despite regionalized collinear Hox gene expression in the lateral plate mesoderm, no forelimb buds 
are induced in the snake and the forelimb gene Tbx5 shows a very strong deregionalized expression that 
seems independent from the Hox expression pattern in the lateral plate (Fig. 17 F). 
 
Figure 17 | Expression of HoxB9 and Tbx5 in the snake lateral plate mesoderm. All tissue shown is from embryos at the second 
day after oviposition. (A) HoxB9 is expressed in the snake with an anterior limit in the lateral plate (red arrowhead) and somitic 
mesoderm (black arrowhead) around pre-vertebra 17. The anterior limit of neural tube expression is marked with a blue 
arrowhead and an example of spinal ganglion expression is marked with a green arrowhead. (B) The forelimb marker Tbx5 is 
expressed throughout the antero-posterior extent of the pre-cloacal lateral plate somatopleure in the corn snake. Expression starts 
more anterior than HoxB9 at the head-trunk transition (marked with a red asterisk). The general lateral plate expression domain is 
indicated with red arrowheads. (c) To determine the position of the lateral somitic frontier in the transversal sections 
immunostaining with MF20 antibody specific for somitic mesoderm was performed. The cryosection shown was taken in the 
anterior trunk. The lateral somitic frontier is indicated with a yellow arrowhead. (D) HoxB9 expression in transversal  cryosection 
taken around pre-vertebra 40 shows expression in lateral plate and somitic mesoderm. (E) Tbx5 expression in transversal wax 
section taken at the mid-axial level shows Tbx5 expression in the lateral plate mesoderm. (F) Schematic comparison of HoxB9 
and Tbx5 expression in the lateral plate. In the chicken HoxB9 and Tbx5 are expressed mutually exclusive at these stages of 
development with Tbx5 being anterior and HoxB9 posterior. In the snake, Tbx5 expression starts more anterior than HoxB9 but 
overlaps posteriorly throughout the pre-cloacal region of the trunk with HoxB9 expression. Thus, despite the “normal” collinear 
pattern of HoxB9 expression, Tbx5 is not regionalized to a forelimb domain but expressed more posterior than expected. Lateral 
plate, somitic, spinal ganglion and neural tube staining as well as the position of the lateral somitic frontier are indicated with 
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different colour arrowheads. Additional snake HoxB9 expression data is provided in the Supplementary Material (Fig. S5) and 
additional chicken and snake Tbx5 data in Fig.S8.  
Discussion 
 
Snakes put their long bodies to good use when moving through dense vegetation, along tree branches or 
in water, which they do with incredible grace. Constricting snakes use their coils to suffocate prey, 
whereas venomous snakes are like a coiled spring that can strike prey at a distance and with terrifying 
speed. Snakes are among the most successful of vertebrate groups, both in terms of number of species and 
geographic distribution160. Elongated bodies have certainly contributed to this success. Model species 
(such as mice) will always be the mainstay of research because scientists can engineer changes in their 
genomes and look for effects on the body plan under controlled conditions161. Biologists are nevertheless 
increasingly considering non-model organisms. In snakes, natural selection has done the genetic 
engineering for us, and so we can study them as experiments performed by evolution. Investigating 
snakes hand-in-hand with model species will provide a holistic view of evolution and development. Snake 
embryos are not easy to work with in the lab because it is difficult to open their eggs without damaging 
the embryo, and obtaining eggs from snakes is not always easy. But if these technical challenges are 
overcome, and snake genome sequences become widely available, a new era of 'evo-devo' research may 
open up. 
We have described a collinear pattern of Hox expression along the primary axis in snake and 
caecilian embryos. At the anterior and posterior regionalized parts of the axis we find that Hox gene 
expression coincides with expressed anatomical transition. Genes, such as HoxA3, HoxB4, HoxA6, and 
HoxC13 have anterior expression boundaries corresponding to clear morphological transitions in the axial 
skeleton (atlas, axis, rib-bearing region and dorsal-caudal transition).  
We however also detect collinear Hox expression boundaries within the dorsal homogenous rib-
bearing part of the skeleton that are not correlated with transitions in the morphology of the axial 
skeleton. Genes such as HoxC6, HoxA7, HoxC8, HoxB9 and HoxC10, that normally act to modify the 
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axial skeleton, display regionalized expression in “silent” domains (i.e. not reflected in anatomy), 
suggesting that they have lost their ancestral effects on vertebral regionalisation. The diffuse anterior 
expression boundaries of these genes in the snake also may reflect loss of involvement in the 
regionalization of the axial skeleton.  
Although snakes lack a neck region, as defined in squamates by the positioning of the forelimb 
girdle, the comparison Hox gene expression in lizards indicates that a relative normal neck region is 
patterned. Interestingly, HoxA6 expression coincides with the beginning of the rib-bearing region in both 
lizards and snake, and our observations do not rule out the possibility that a single Hox gene is 
responsible for rib formation. Apparently, though, the mechanism of posterior prevalence, according to 
which more posterior Hox genes modify these ribs or suppress rib formation completely, is not 
operational.  
The snake lateral plate mesoderm shows a collinear pattern of Hox expression as has been 
implicated in the positioning of the limbs in chicken. No limb buds are present in corn snakes however, 
and neither is any molecular trace of a discrete forelimb. In contrast to the potential upstream 
regionalizing signal provided by differential Hox expression (especially HoxB9), the expression of Tbx5 is 
highly deregionalized.  
In summary, our data suggest that the axial expression patterns of Hox genes in the somitic and 
lateral plate mesoderm of the snake and caecilian do not induce the same downstream responses as they 
do in the mouse. And so, while some ancestral features of the ‘Hox code’ are retained in the two long-
bodied lineages studied here, they result in a remarkably different phenotype from that seen in the mouse. 
We provide evidence that, besides changes in expression domains through alterations in cis-
regulation, alterations in downstream gene interpretation may also play an important role in the evolution 
of a snake-like body plan. These changes in downstream response to the Hox pattern could, in principle, 
occur at two levels. First, the response of downstream genes could be altered through changes in cis-
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regulatory sequences leading to a different response to Hox genes. Alternatively, changes in Hox coding 
sequences could lead to the differential activation of target genes. The contribution of coding sequence 
evolution to evolutionary modifications has received ample attention recently 162,163 and it has been shown 
that for instance changes in Ubx coding sequence were essential for changes in invertebrate 
bodyplans164,165. The possibility exists that in snakes and caecilians a similar mechanism is involved in 
changes in their body plan. Transgenic gain-of-function assays in mouse should reveal whether snake and 
caecilian Hox genes do indeed have different inducing properties from those of their mouse orthologs. 
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Material & Methods 
 
Corn snake and bearded dragon embryos were obtained from private breeders in the Netherlands and 
caecilian embryos were collected from the wild in Thailand, in accordance with local and international 
regulations. Alizarin red and alcian blue staining was carried out according to standard protocols, and 
embryos were cleared in methyl salicylate.  
Genes were cloned by PCR from Patherophis spiloides cDNA or Pantherophis guttatus genomic DNA 
and caecilian genomic DNA and are deposited in genebank under accession numbers GQ176238-
GQ176263.  
Immunostaining and histology was carried out according to standard procedures. The MF-20 antibody 
was obtained from the Developmental Studies Hybridoma Bank, University of Iowa. In situ hybridization 
was carried out according to standard protocols. Pre-vertebral axial formulae were determined by somite 
counting and, if visible in the in situ hybridization wholemounts, the position of the first spinal ganglion. 
In corn snakes and bearded dragons, we used the amniote standard formula where the 1st pre-vertebra 
forms from somite 5-6. In caecilian we determined (by Alcian blue staining and the position of the first 
spinal ganglion) that the 1st vertebra forms from somites 3-4, which is the same as in Xenopus laevis. 
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Chapter 5: Massive Evolutionary Expansion of Venom Genes in the 
King Cobra Genome 
 
Vonk FJ, Henkel CV, Casewell NV, Kini RM, Kerkkamp HM, Wuster W, Castoe TA, Ribeiro 
JMC, Spaink HP, Jansen HJ, Hyder SA, Arntzen JW, Pollock DD, van den Thillart GEEJ, 
Boetzer M, Pirovano W, Dirks RP and MK Richardson.   
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Snake venom is a complex mixture of proteins and peptides evolved to immobilize prey and deter 
predators
166
. The rapid evolution of venom toxins is part of a predator-prey ‘arms race’ that 
represents a classic model for studying molecular evolution
13,25,27,167,168
. Snake toxins are thought to 
evolve from normal physiological proteins through gene duplication and recruitment to the venom 
gland
169-172
. However, in the absence of genomic resources, these hypotheses remain speculative.  
Using Illumina sequencing technology we have produced a draft genome of an adult male 
Indonesian king cobra (Ophiophagus hannah), and have deep-sequenced its venom gland 
transcriptome. Comparative genomics revealed evidence of tandem duplication of genes encoding 
physiological L-amino acid oxidase, cysteine-rich secretory proteins and metalloproteinases, 
followed by recruitment through selective expression in the venom gland. By contrast, nerve growth 
factor toxins appear to have evolved by duplication and dual recruitment, while hyaluronidase and 
phospholipase B evolved by recruitment of existing physiological genes without further duplication, 
similar to acetylcholinesterase
173
. We also identify 21 different three-finger toxin (3FTX) genes in 
the genome, suggesting a massive expansion of this family. We find a significant variation in the 
expression levels of these 3FTX genes in the venom. These data show that venom proteins originate 
and evolve through multiple distinct mechanisms. These sequences provide a valuable resource for 
studying rapid evolution of gene sequences and the evolution of recruitment of genes to different 
tissues.  
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Many advanced snakes (Caenophidia174) use venom, with or without constriction, to subdue their prey. 
Venom is produced in a post-orbital venom gland that probably evolved from an ancestral gland in the 
posterior part of the mouth2. There is evidence that the evolutionary history of venom in reptiles may be 
traced as far back as Triassic lizards175. The pharmacologically-active proteins and peptides in venom 
target a wide variety of proteins including receptors, ion channels and enzymes176. Their actions include 
disruption of the central and peripheral nervous systems, the blood coagulation cascade, the 
cardiovascular and neuromuscular systems, and homeostasis. Only in recent years has the remarkable 
variability of venom composition at the taxonomic, population, and individual levels been fully 
appreciated, and a start made to investigate the underlying ecological drivers and molecular 
mechanisms176.  
It is thought that toxin gene families have evolved through duplication of normal physiological 
genes170-172,177, followed by recruitment and expression in the venom gland. However, this hypothesis has 
not been verified with genomic data. Therefore, we have produced a draft genome of an adult male 
Indonesian king cobra (Ophiophagus hannah) and deep-sequenced the transcriptome of its venom gland 
using Illumina technology. The sequence data were first assembled de novo into contigs, which were 
subsequently oriented and merged in scaffolds (see Methods summary). Haploid genome size was 
estimated using flow cytometry to be around 1.36-1.59 Gbp. Our assembled draft has an N50 contig size 
of 6533 bp, and an N50 scaffold size of 242 Kbp. The contigs sum to 1.34 Gbp, and the scaffolds (which 
contain gaps) to 1.59 Gbp.  
Mitochondrial genome phylogeny confirms that the male specimen we used for genome 
sequencing clusters in the Ophiophagus group with other king cobras (Fig. 18). Using Augustus gene 
prediction178, and our transcriptome data we estimate that the king cobra has approximately 22,183 
protein-coding genes (data not shown). Although some of the predicted genes will be either part of a gene 
that spans multiple scaffolds, or will represent mispredictions, the values suggest that the total number of 
genes in snakes and other amniotes is similar179-181.   
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Figure 18 | Mitochondrial genome phylogeny showing that our male Indonesian king cobra (Ophiophgus hannah) groups with 
the king cobra from China (Yi Chuan. 2010 Jul;32(7):719-25). Note that the Naja naja is in fact a taxonomy error because the 
sample was taken from a Naja atra (Wolfgang Wuster, pers comm).  
We identified 17 different toxin families in the venom gland transcriptome by blasting against 
reference sequences (from www.ncbi.nlm.nih.gov, and see Fig. 19) and annotated nine of them in the 
genome (Figs. 20-25). These nine include: three-finger toxins (3FTXs), L-amino acid oxidase (LAAO), 
phospholipase A2 (PLA2), phospholipase-B (PLB), cysteine-rich secretory protein (CRISP), 
metalloproteinases (ADAM), nerve growth factor (NGF), hyaluronidase (HYA), cobra venom factor 
(CVF). Three of these (NGF, PLB and CVF) have not previously been reported in king cobra venom.  
 
 
Figure 19 | (page 64) Relative abundance of the venom toxins in the venom gland transcriptome. The percentages are calculated 
based on the expression value of the transcripts sequenced from the venom gland transcriptome. The most abundant family is the 
threefinger toxins (31,54% of all toxin transcripts identified), represented in the genome by at least 21 different isoforms (see 
also Fig. 20). 
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  Proteins in two of these families (3FTX and PLA2), are known to exhibit a wide variety of toxic 
and pharmacological effects including neurotoxicity, cardiotoxicity and hemolysis182,183. We find 
evidence for massive expansion in the genome in both these families. We found seven different exons-2 
that belong to PLA2 (Fig. 20). These genomic sequences do not contain premature stop codons or 
frameshifts indicating that they do not contain pseudogenes.  
 
Figure 20 | Massive expansion of PLA2 genes. Alignment of multiple PLA2 genomic hits. Note no stopcodons or frameshifts in 
the sequences.  
3FTXs are three-exon genes, of which the second exon is most readily identified. We found 21 of 
these exons-2 in the genome (Fig. 21). However, some of these are on small contigs and covered by 
relatively many sequencing reads, indicative of high copy numbers. Therefore, the actual diversity of full-
length 3FTX genes may be even higher. Most exons-2 are expressed in the venom gland, although the 
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Figure 21 | Unrooted phylogenetic tree constructed from all different exon 2 sequences of the three finger toxin genes. Isoform 
19 contains a premature stop codon, thus most likely is a pseudogene. Green circles indicate relative expression levels (on a 
logarithmic scale), blue circles apparent genomic copy numbers, both based on local coverage by venom.  
| |
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expression levels differ by five orders of magnitude (Fig. 21). One non-expressed isoform (isoform 19) 
contains a premature stop codon and may be part of a pseudogene (Fig. 22). The presence of multi-copy 
and highly expressed exons is clustered in several 'successful' branches of the 3FTX gene family, and 
genomic copy number and expression level in the venom gland appear to be correlated (Fig. 20).  
 
Figure 22 | Alignment of multiple 3FTX isoforms. Note that only isoform19 (Gn_3FTx iso19) contains a stopcodon 
and may thus be a pseudogene.  
There is a substantial difference in expression levels of each of the 3FTX isoforms (Fig. 20). 
Isoform diversity and toxin expression levels are thought to be important in optimization of the prey-
specificity of the venom — more so than differences in the representation of entire toxin families and the 
recruitment of novel toxin families184. In general, a high genomic copy number is associated with a high 
relative expression value (Fig. 20). All relatively ‘successful’ branches of 3FTX genes (the ones that are 
expressed heavily) share sequence similarities (Fig. 22), indicating conservation of important functions.  
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Reptile venom CRISPs act as regulators of several types of ion channels185. We find three CRISP 
genes in tandem in the king cobra genome (Fig. 23), only two which are represented in our venom gland 
transcriptome (Fig. 23). Together with the comparative genomic data (Fig. 23), this is consistent with an 
evolutionary scenario in which the two venom genes have been derived by tandem duplication from the 
non-venom expressed (physiological) CRISP gene.  
 
Figure 23 | Comparative genomic architecture of the CRISP genes. a, chicken (Gallus gallus); b, anole lizard (Anolis 
carolinensis); and c, king cobra (Ophiophagus hannah). Chick and Anolis sequences are from www.ensembl.org. The exploded 
views show scale diagrams of the exons and introns. Scale bar refers to the exploded views. NNN, unresolved sequence. In the 
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Anolis genome we annotated three CRISP genes with different orientations. Based on the relative sizes of the second introns the 
two ‘venom’ CRISP genes are comparable to isoform 3 in Anolis. In chicken we could only find one CRISP gene. 
 
 
 
Figure 24 | The scaffold containing three CRISP genes with different isoform transcripts (see Figure 23c) mapped on as follows: 
a) isoform 1; b) isoform 2; c) isoform 3. As can be seen, only the first two isoforms are expressed in the venom gland; d) 
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alignment of the three CRISP genes with reference sequences showing that our identified genes belong to the CRISP family. 
Isoform1 is opharin and isoform 2 is ophanin. 
Venom metalloproteinases belong to the ADAM family and target various stages of blood 
coagulation and platelet aggregation and are responsible for hemorrhage186. We also find three ADAM 
genes in tandem, only one of which was expressed in the venom gland transcriptome (Fig. 25).   
 
Figure 25 |  Scaffold containing three ADAM genes; b) isoform 1; c) isoform 2; d) isoform 3. Only isoform 2 is expressed in the 
venom gland (data not shown). Amino acid alignments of these three metalloproteinase genes with the single transcriptome 
sequence (not shown) shows that one gene is identical and confirms its expression. Isoform 1 has a longer C-terminal tail. In O. 
hannah isoform 2 is expressed in the venom gland, while in Naja atra (a different elapid snake) isoform 3 appears to be 
expressed, since we find that N. atra metalloproteinase sequence is more similar to isoform 3 than isoform 2 
LAAO produces H2O2 during oxidation of amino acids leading to cytotoxicity and inhibition of 
platelet aggregation (and is responsible for the yellow color of the venoms)187. We find two LAAO genes 
on two different scaffolds (Fig. 26 a). Based on the mapping of venom gland transcriptome reads (not 
shown), only one LAAO gene appears to be expressed in the venom gland; the other is presumably the 
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non-venom, physiological gene. To the best of our knowledge, non-venom LAAO proteins have not been 
found in reptiles before, although they are found widely among vertebrates.  
 
Figure 26 | a, Genomic architecture of l amino acid oxidase (LAAO) genes in the chicken and king cobra. b, scheme of the 
genomic context of the hyaluronidase genes in the mouse (Mus musculus) and king cobra. Mouse genomic sequences from 
www.ensembl.org. Scale bar refers to the exploded views. NNN, unresolved sequence. 
|
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The role of venom NGF is not clear98.  We find two different NGF genes, both of which are 
encoded by a single exon; and both of them are expressed in the venom gland (Fig. 27). Presumably, one 
or both of these has duplicate functions (in both venom-gland and in other tissues). Venom hyaluronidase 
plays a key role as the venom ‘spreading factor’, making tissue more permeable188. We annotated two 
hyaluronidase genes in the king cobra genome, both lie downstream of the WASL gene, and we find the 
same arrangement in the mouse genome (Fig. 26 b). Only the gene corresponding to HYALP1 is 
expressed in the venom gland (data not shown), which is interesting because in the mouse this gene 
appears to be inactive189. This synteny is consistent with a scenario in which the duplication of the 
hyaluronidase gene took place long before one of the copies was recruited to the venom gland.  
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Figure 27  | Mapping of the transcriptome reads onto the two scaffolds containing two NGF genes shows that both of these genes 
are expressed in the venom gland; a) isoform 1; b) isoform 2; c) Alignment of the two NGF genes with reference sequences 
showing that our identified genes belong to the NGF gene family (data not shown).  
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Recently, PL-B was also found to be expressed in the venom gland190 but its role in toxicity is yet 
unclear. We could only find one PL-B gene (Figure 28). This indicates that an existing PL-B gene was 
recruited to the venom gland. Thus HYA, NGF and PL-B genes appear to be recruited for expression in 
the venom gland without gene duplication being involved. In the case of the Asian krait (Bungarus 
fasciatus) Acetylcholinesterase toxin, it was shown that both the neuronal and the venom enzymes are 
encoded by the same gene, although alternatively spliced173.  
 
Figure 28  | Scheme of the genomic synteny of the PL-B genes in the Anolis, Gallus and king cobra. Anolis, Gallus genomic 
sequences from www.ensembl.org. Mapping of the transcriptome reads onto one scaffolds containing the PL-B gene shows that 
this gene is expressed in the venom gland (data not shown). This synteny is consistent with the scenario of recruitment of the 
existing PLBD1 into the venom gland during snake evolution. The alignment of the PL-B gene with reference sequences showing 
that our identified genes belong to the PL-B gene family (data not shown).  
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It has been shown, in the case of factor X toxin in the rough-scaled snake (Tropidechis carinatus), 
that a specific insertion in the promoter region of the toxin was responsible for the selective recruitment to 
the venom gland169. We have scanned all our scaffolds for this sequence but could not find anything 
similar. This suggests that that the specific insertion is not a universal feature of toxin gene recruitment, 
and that several distinct mechanisms are responsible for the origin and recruitment of venom proteins.  
Conclusion and discussion 
Comparative genomics has revealed flexible mechanisms of mutation and recruitment of venom genes. 
We found evidence of tandem duplication of genes encoding physiological L-amino acid oxidase, 
cysteine-rich secretory proteins and metalloproteinases, followed by recruitment through selective 
expression in the venom gland. By contrast, nerve growth factor toxins appear to have evolved by 
duplication and dual recruitment, while hyaluronidase and phospholipase B evolved by recruitment of 
existing physiological genes without further duplication. We also identify 21 different three-finger toxin 
(3FTX) genes in the genome, suggesting a massive expansion of this family. We find a significant 
variation in the expression levels of these 3FTX genes in the venom. Our data therefore shows that venom 
proteins originate and evolve through multiple distinct mechanisms.  
The king cobra genome is an important resource for studying molecular evolution. The powerful 
combination of genomics with transcriptomics here used lead to the identification of toxin genes 
previously unknown in the king cobra. Because of the massive functional diversity known to exist not 
only between toxins but also their isoforms176,  functional studies of these new toxins could prove to be of 
great interest.   
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Methods summary  
king cobra tissue acquisition and processing. All animal procedure complied with local ethical 
approval. Genome sequencing was done on a blood sample obtained from an adult male king Cobra from 
a captive specimen that originated from Bali, Indonesia. Blood was obtained by caudal puncture and 
frozen in liquid nitrogen. The venom gland and other tissue samples were dissected from a freshly 
euthanized second adult male specimen and stored in RNAlater.  
Sequencing and assembly. We used a whole-genome shotgun sequencing strategy and Illumina 
Genome Analyser sequencing technology. Two paired-end and four mate pair libraries were constructed 
with insert sizes of up to 15K nucleotides. In total, we generated 41.2 Gbp (approximately 28x genome 
coverage) of sequence data for contig building, 21.1 Gbp for scaffolding, and 1.7 Gbp for the 
transcriptome. We built contigs from the short reads using the CLC bio de novo assembler (CLC bio, 
Aarhus, Denmark) and oriented these contigs using SSPACE. A more extensive methods section is 
included in the supplementary information. 
Annotation and gene prediction. Gene prediction was carried out automatically using Augustus 
software178, using venom gland transcripts as hints. Further extensive manual annotation was performed 
to establish the intron-exon boundaries.  
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Chapter 6: An Efficient Analytical Platform for On-line Microfluidic Profiling of 
Neurotoxic Snake Venoms Towards Nicotinic Receptor Like Affinity  
Heus F, Vonk FJ, Bruyneel B, Smit AB, Lingeman H, Richardson MK, Niessen W and J Kool.  
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The highly variable toxic peptides in snake venoms target a myriad of neurotoxic and hemotoxic 
receptors and enzymes and comprise highly interesting candidates for drug discovery. Venom 
profiling studies are normally directed either at identification of venom peptides or at biological 
activity using elaborate and complicated workflows employing relatively large amounts of precious 
venom. We have developed a microfluidic on-line screening approach utilizing nano-LC–MS with 
parallel bioaffinity detection, which enables efficient correlation of bioaffinity to identity of the 
venom peptides. Using the acetylcholine binding protein (AChBP) as biological target, we evaluated 
our technology with high-affinity α-bungarotoxin and hemotoxic/proteolytic Vipera ammodytes 
venom spiked with α-bungarotoxin. The methodology was applied to profile the venoms of 
Dendroaspis jamesoni kaimosae, Naja annulifera and N. nivea, which took less than two hours per 
venom. The data yielded over 20 AChBP ligands of which the corresponding accurate masses were 
used to retrieve information from literature regarding their function and targeting specificity. We 
found that from these 20 ligands, 13 were previously reported on, while information on the others 
could not be found. Our data demonstrated that nano-LC-MS coupled to an on-line biochemical 
assay is a promising analytical approach for rapid identification of bioactive peptides in snake 
venoms. 
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Introduction 
Recent advances in scientific understanding of diseases have raised hopes of an increase in the number of 
novel drugs reaching the market. Further, many potentially disease-related orphan receptors are now 
being investigated. It is therefore disappointing to realise that the number of drugs reaching the market is 
actually dwindling191. One of the solutions to this problem is the exploration of natural sources, such as 
animal venoms, as to increase the numbers of potentially new lead compounds. Why? Possible reasons: 
venoms are highly potent because they are under extreme strong natural selection176,192. Venoms often 
contain multiple novel compounds, free from IP restrictions. They have also provided many new drugs or 
even new classes of drugs, in the past.  
There is huge variability in snake venom composition15,184,193 due to an accelerated form of 
mutation and evolution25,33,192,194,195 that is currently not understood at the molecular level. Venomous 
snakes differ in their venom composition not only between species (interspecific) but also within a 
species (intraspecific). In order to exploit this massive natural resource, several challenges have to be 
resolved. These include bio-analytical challenges such as: 1) the complex nature of the samples and the 
intrinsically time-consuming process of elucidation, 2) the occurrence of synergistic actions between 
components in a complex natural extract, and 3) sourcing adequate quantities. For these and other 
reasons, pharmaceutical companies scaled-down or even abandoned their natural extract drug discovery 
pipelines. Nevertheless, many drugs approved during the last decades are based on natural products 196. 
Another potential reason for abandoning natural extract product pipelines is that most of them focused on 
plant and fungal derived bioactives197, because these mostly small molecule compounds fitted well in 
their small molecule drug discovery pipelines. Traditional problems with peptide and protein derived 
drugs are amongst others due to issues with (oral) drug administration, bodily distribution (e.g. limited 
crossing of the blood-brain barrier) and immunogenicity issues. Advanced formulation methodologies, 
administration routes198-201, protein engineering and production techniques202-204,204, as well as current 
knowledge and available technologies dealing with immunogenicity and immunotoxicity205-209 have now 
brought these biopharmaceuticals back into consideration as candidate drugs. 
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Great advances have been made in protein-based pharmaceuticals during the last ten years210-213. 
In this regard, venom peptides also gained interest. A couple successful examples include: (i) Prialt 
(Ziconotide), a non-opioid painkiller derived from the neurotoxic venom of a predatory cone snail (Conus 
Textilus) and used to treat severe chronic pain by injection directly into the spinal fluid 214; (ii) Byetta 
(Exenatide), a drug against diabetes TypeII derived from the venom of the Gila monster (Heloderma 
suspectum)215; ACE inhibitors used for the treatment of hypertension and derived from a compound in the 
venom of the South American Lancehead snake (Bothrops jararaca)76; and the antiplatelet drug 
Integrillin (Eptifibatide) derived from a compound the venom of the Saw-scaled viper (Echis carinatus) 
and used to reduce the risk of acute cardiac ischemic events in patients with unstable angina. In addition 
to the drugs that have been derived from animal venoms, there have also been some successful 
applications in diagnostics like the detection of lupus anticoagulants (abnormally high risk of blood 
clotting ) using Taipan venom (Oxyuranus scutulatus)216. Some snake toxins have also been used to probe 
receptors. The deciphering of the molecular structure of neurons was made possible by the use of 
bungarotoxin from the venom of the banded krait (Bungarus multicinctus) and led to the discovery of a 
receptor for acetylcholine217: the acetylcholine receptor.  
One of the specific difficulties of effective natural extract screening is the accurate and rapid 
bioactivity/identity correlation of bioactives with current traditional effect directed analysis (EDA) 
methodologies218. EDA approaches are today’s standard for bioactive mixture analysis and are widely 
applied in environmental219-221  and natural product screening222-224, as well as animal venom profiling225. 
In this approach, bioactive compounds are separated and subsequently fractionated, e.g., with liquid 
chromatography (LC), into a number of fractions, after which each fraction is tested for a specific 
bioactivity. Ultimately, the bioactives are analysed with mass spectrometry (MS) to identify them. 
However, EDA studies often fail to identify the bioactive compounds, because even after repeated 
fractionation, biologically active fractions often remain too complex for chemical identification. This 
might result in wrong interpretation and erroneous identification of bioactives, especially for those 
bioactives with high affinity but low abundance. These are usually present in the same fraction with high-
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abundance non-bioactive compounds, which impairs their detection. Some snake toxins are also only 
present in very low amounts. Nerve Growth Factor toxins (NGF) – for example – are only present in 0.1-
0.5% in snake venom and are easily missed out. But NGF from the venom from cottonmouth vipers 
(Agkistrodon piscivorus) allowed the authors to study the mechanisms regulating cell and organ growth99, 
for which they were awarded the Nobel prize in 1986. Hence it is crucial to take into account these low 
abundance bioactives in order to make sure the full potential of venoms are realized.  
Furthermore, the freeze-drying (lyophilisation) of the chromatographic carrier fluid from the 
fractionated sample may deactivate toxins, by altering the tertiary structure of proteins by (for instance) 
unfolding, which might lead to false negatives. Additionally, the EDA workflow requires large amounts 
of sample, which is difficult in the case of the very precious venoms. Even though some snake species 
produce relatively large amounts of venom, most don’t166. Most snakes produce less than a milligram of 
venom per milking226, severely hampering efficient venom profiling.  
Even though some snake venom proteomes have been completely elucidated and sequenced, 
many toxins have unknown functions and protein targets. Of these “orphan toxins’, only a hypothesised 
functionality is known by sequence homologies with toxins having known bioactivities. And based on the 
large functional diversification followed my only minor mutation of some of the toxin families47, it is 
difficult to estimate function based on sequence similarity. These toxins are often only classified broadly 
as cytotoxic, cardiotoxic or weak-neurotoxic227, including a myriad of different (unknown) receptors and 
proteins recognized or bound.   
Due to current advances in analytical strategies and microfluidics technologies, effective 
screening for some pharmaceutical targets is currently possible with so-called on-line high-resolution 
screening (HRS) approaches 228-232: chemical analysis and biological screening are integrated in a single 
instrument platform by post-LC continuous-flow biochemical detection and parallel MS analysis232.  
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Analyzing natural extracts with a HRS platform can reveal in a single measurement the number 
and chemical nature of the majority of bioactive compounds, with their affinity towards the target 
receptor analysed 233-236. Unfortunately, as stated above, the often yields in animal venoms obtained 
during a single milking are not compatible with the larger amounts required for traditional on-line HRS 
approaches. We recently developed a miniaturized HRS methodology for analysis of small compound 
libraries where nano-LC was hyphenated on-line to a microfluidic biochemical detector237. This 
methodology however, although it would in theory allow for analysis of intrinsically low venom amounts, 
is unsuited for profiling snake venoms as the complexity in this case overwhelms the analytical system. 
The main issue here is that the system is only able to assess bioaffinity in one run therefore necessitating a 
second nano-LC-MS analysis for peptide identification. Now, the main bottleneck becomes apparent as 
repeatability of nano-LC systems is by far not sufficient for the demanded precision in retention time of 
eluting peptides. Therefore, the bioactivity of peptides can never be correlated to their identity. For 
identification purposes, a nano-electrospray MS (nano-ESI-MS) has to be placed in parallel via a post-
column split as is traditionally done in on-line HRS approaches232. Performing post-column splits after 
nano-LC, however, is very tedious, error prone and unstable. Furthermore, often the split and the flows 
cannot be operated in a controlled manner. Therefore, this endeavour has been avoided by the analytical 
community. Nano-LC-MS is also the analytical technique of choice in proteomics approaches due to its 
mass-sensitive detection and low sample consumption, and well suited as most snake venoms comprise 
predominantly peptides and proteins. Many (snake) venomics studies nowadays comprise nano-LC-MS in 
their analytical strategies7.  
During the last ten years, drug discovery directed at the α7 nicotinic acetylcholine receptor (α7 
nAChR) experienced a great leap by using the acetylcholine binding protein238,239. Ls-AChBP is a stable 
structural homologue of the extracellular ligand binding domain of the α7 nAChR. It was first crystallized 
and validated as model for nAChRs, especially the α7 nAChR, by us240 in 2001 and has often been used 
as nAChR model since then. In this regard, it is used as mimicking drug target for example to identify 
nAChR ligands241,242, and very well suited for HRS approaches, as was recently demonstrated by us243. 
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Subsequently, we developed a miniaturized screening format for bioaffinity profiling of small molecular 
ligands towards the Ls-AChBP237. This system, however, only allowed bioaffinity profiling and did not 
involve parallel compound identification by MS. 
In the current work, the miniaturized HRS approach was applied to efficient venom profiling of 
mainly snake venoms from species belonging to the Elapidae (cobras, mambas and relatives). The HRS 
system comprises a post-column nano-flow split which directs the chromatographic effluent to mass 
spectrometric and on-line biochemical detection allowing for simultaneous correlation of separated 
bioactive venom toxins with their corresponding accurate mass. This approach may direct subsequent 
targeted purification (with straightforward LC-MS). The analytical approach led to the identification of at 
least 20 bioactive peptides with Ls-AChBP affinity and assigned accurate mass, in the venoms of the 
species examined: the Mozambique spitting cobra (Naja mossambica); the black-tailed Jameson’s mamba 
(Dendroaspis jamesoni kaimosae); the banded cobra (Naja annulifera); and the Cape cobra (Naja nivea). 
From horned viper (Vipera ammodytes) venom - a member of the Viperidae family known for having 
mainly hemotoxic/proteolytic peptides -  also a low-affinity bioactive peptide was discovered.  
Experimental 
Chemical and biological reagents  
Ls-AChBP (from snail species Lymnaea stagnalis) was expressed from Baculovirus using the pFastbac I 
vector in Sf9 insect cells and purified from the medium as described by (ref 244). The fluorescent-tracer 
ligand DAHBA, (E)-3-(3-(4-diethylamino-2-hydroxybenzylidene)-3,4,5,6-tetrahydropyridin-2-
yl)pyridine, was synthesized in-house243. NaCl, trizma base, HCl, formic acid (FA), DL–dithiothreitol, 
guanidine-HCl, rhodamine-110, 5% dimethyldichlorosilane (DMDCS) and α-bungarotoxin (α-BTX) were 
purchased from Sigma-Aldrich, (Zwijndrecht, The Netherlands). KH2PO4, Na2HPO4 and NH4HCO3 were 
obtained from Riedel-de Haën (Seelze, Germany). I-Nicotine (99.0%) was purchased from Janssen 
Chimica (Beerse, Belgium). Enzyme-linked immunosorbent assay (ELISA) blocking reagent (ELISA BR) 
was purchased from Hoffmann-La Roche (Mannheim, Germany). ULC/MS grade methanol (MeOH; 
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99.98%) and acetonitrile (ACN; 99.97%) were purchased from Biosolve (Valkenswaard, The 
Netherlands). HPLC grade water was produced using a Milli-Q purification system from Millipore 
(Amsterdam, The Netherlands).  
Instrumentation 
Microfluidic confocal fluorescence detection system: The complete system consisted of a nano-LC unit, 
an MS, an on-line chip functioning as biochemical reactor, where the LC flow and a bioassay solution 
were mixed, and a microfluidic LED-based LIF detector as described by (ref 237). The complete HRS 
platform is schematically shown in Fig. 29. 
Nano-LC and solvent delivery system: The Ultimate nano-LC system with a Famos autosampler was 
from LC Packings (Amsterdam, The Netherlands). The system was operated at 400 nL/min. Mobile phase 
solvent A consisted of water and 0.1% Tri Fluoro Acetic acid (TFA) and solvent B of ACN and 0.1% 
TFA. Sample volumes of 500 nL were injected into the analytical capillary column (150 mm × 75 µm 
internal diameter (i.d.)) packed in-house with Aqua C18 particles (particle size 3 µm, 200 Å pore 
diameter; Phenomenex, Torrance, CA, USA). For venom analysis, a 90-minute gradient elution was 
applied running 5 min isocratic at 5% solvent B, then rising to 15% solvent B in 10 minutes, followed by 
a rise towards 45% solvent B in 60 min, where after solvent B was set to reach 70% during 10 minutes, 
running isocratically at 70% for 5 minutes. To prevent particulate matter to clog the capillary column, the 
column inlet was connected to a low dead volume union containing a filter capsule (type M-572 and M-
128 respectively, Upchurch Scientific, Oak Harbor, WA, USA). The column exit was connected to a low 
void volume T-connector where the effluent was split to the MS and the on-line bioassay by two pieces of 
bare fused-silica (1,000 mm × 10 µm i.d.). All fused-silica capillaries used for connections to and from 
the chip were purchased from BGB Analytik AG, Schloßböckelheim, Germany. 
Microfluidic chip: The microfluidic chip and the chip holder (type 4515), produced by Micronit 
Microfluidics, (Enschede, The Netherlands), was described in detail elsewhere237. The open tubular 
microreactor had a total volume of 4 µL. The reactor had two inlets and one outlet. One inlet was used to 
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connect the nano-LC carrier flow; the other inlet to infuse the AChBP and tracer ligand DAHBA237,243 at a 
flow rate of 5 µL/min by a Model 980532 syringe pump (Harvard Apparatus, Holliston, MA, USA). The 
chip outlet was connected via a deactivated fused-silica to the microfluidic LIF detector, as described237.  
Microfluidic LED-based LIF detector: The flow cell of the detector consisted of a 150 µm i.d. extended 
light path “bubble-cell” with 50 µm i.d. connecting capillaries (G1600-64232, Agilent Technologies, 
Amstelveen, The Netherlands). This bubble cell served as the actual flow-through detector cell. Light 
emanating from a high-intensity LED passed a 465 nm single band pass filter, was collimated by a lens, 
reflected by a dichroic mirror under 90° and focused into the centre of the bubble cell by 20× quartz 
microscope objective. Emitted light passed the same dichroic mirror, a focusing lens, and a 520 nm single 
band pass filter, after which it was detected by photomultiplier tube. A detailed description of this 
detector can be found elsewhere237.  
Nano-LC/MS: A Shimadzu (‘s Hertogenbosch, The Netherlands) ion trap – time-of-flight (IT-TOF) 
hybrid mass spectrometer equipped with a Picoview nano-ESI source from New Objective (Woburn, MA, 
USA) was operated in positive-ion mode. A 40 mm × 180 µm o.d. × 30 µm i.d. stainless steel emitter was 
used (ES522, Proxeon/Thermo Scientific, Waltham, MA, USA), functioning as the spray needle. The 
spray needle was connected to the nano-LC system via a 1,000 mm × 10 µm i.d. bare fused-silica 
capillary by a low void volume connector (type P-720, Upchurch Scientific) which was integrated in the 
nano-ESI source. The temperature of the heating block and curved desolvation line were set to 200°C. 
The interface voltage was set at 1.7 kV, resulting in a current of ~32 µA.  
 
Biochemical assay and samples 
Biochemical assay: Fresh solutions of 5 nM Ls-AChBP and 15 nM DAHBA were made every day by 
dissolving in a bioassay solution containing 1 mM KH2PO4, 3 mM Na2HPO4, 0.16 mM NaCl, 20 mM 
trizma base/HCl at pH 7.5 and 400 µg/mL ELISA BR. The bioassay solution was housed in a 2.5 mL 
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syringe (type 1002LTN, Hamilton, Bonaduz, Switzerland) which was kept at 4 °C. The on-line bioassay 
itself was performed at 22 °C.  
Snake venoms: Lyophilized venoms samples of Naja mossambica, N. annulifera, Dendroaspis jamesoni 
kaimosae and N. nivea were acquired as described by (ref 166). Vipera ammodytes and N. pallida venom 
were purchased from Sigma Aldrich. About 2 to 3 mg of lyophilized crude venom sample was dissolved 
in water/ACN/TFA 95:5:0.1% at a concentration of 10 mg/mL and subsequently centrifuged at 13,400 
rpm for 10 min to remove particulate matter. Aliquots of these samples were stored at -20°C until further 
use. Before analysis, 40 µM internal standard nicotine was added together with three peptides at 2 µM 
each. The resulting venom solutions were directly injected in duplicate onto the nano-LC system for 
parallel bioaffinity screening and MS identification. Samples were re-analyzed at lower or higher 
concentrations whenever necessary. The nicotine served as an internal standard and for alignment 
between the MS chromatograms and the bioassay readout. In the same way, the three reference peptides 
served to align MS data between different runs, whenever necessary. These peptides were Met-
Enkephalin, Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 (Bachem, Bubendorf, Switzerland) and 
Enkephalin acetate salt hydrate (Sigma Aldrich). 
 
Results and Discussion 
This works describes the use of an efficient analytical platform for the profiling of neurotoxic snake 
venoms. The technology is based on an on-line HRS approach in which the on-line biochemical assay 
assesses bioactivity towards Ls-AChBP, mimicking predominantly neuronal nAChR binding. Parallel MS 
analysis provides accurate masses of the bioactive peptides for identification purposes. We developed a 
miniaturized nano-LC setup to overcome the main challenge of the limitation of the amount of venom 
available per snake species, and to provide sufficient sensitivity. This miniaturized setup was developed 
previously by using an on-line microfluidic chip (4 µL) and nano-LC237. In the current setup (Fig. 29), an 
additional post-column split is introduced directing half of the 400 nL/min effluent from the nano-LC to 
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the nano-ESI interface. The other half is directed to the microfluidic chip where it is mixed continuously 
with the bioassay solution, which is infused at 5 µL/min by a syringe pump. The outlet of the chip is 
connected to the confocal LED-induced fluorescence detector, which monitors bioaffinity of the eluting 
toxins after in-flow incubation. The bioassay is based on fluorescence enhancement in which the tracer 
ligand DAHBA shows increased fluorescence yield upon binding to the AChBP. As an eluting peptide 
competes with DABHA for Ls-AChBP binding, a negative peak in the signal is observed. Bioactives can 
subsequently be purified by normal-bore LC(-MS) in a straightforward fashion for further 
pharmacological studies on nAChRs.  
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Figure 29 | Schematic view of the complete analytical setup from 'milking' venom to our developed method. The bioassay 
solution containing AChBP and the tracer molecule DAHBA were infused by a syringe pump at 5 µL/min and mixed with the 
nano-LC effluent running at 400 nL/min, in the 4-µL open tubular reaction chamber of the microfluidic chip. The chip’s outlet 
was hyphenated to the bubble cell capillary wherein light emanating from the high intensity LED was focused. Emitted light from 
the AChBP/DABHA complex was subsequently detected by the photomultiplier tube. The setup is described in detail in the 
“Experimental section”. 
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Method evaluation for the screening of snake venoms  
In order to evaluate the applicability and performance of the miniaturized methodology for the screening 
of bioactive peptides in snake venom, a standard addition study was performed first, to assess sensitivity, 
reproducibility, correlation of peak shapes observed in MS and the biochemical assay, and (post-column) 
band broadening. This was done by injecting 5 µg venom from the sand viper (Vipera ammodytes) in a 
500 nL sample containing increasing amounts of α-bungarotoxin (α-BTX). Vipera ammodytes venom is 
primarily hemotoxic, thus not containing abundant, highly active neurotoxic peptides (with probable 
affinity towards Ls-AChBP). In this way, the highly active spiked α-BTX was studied in a complex 
venom matrix without other significant bioactives. This allowed determination of whether the HRS 
system is capable of pinpointing a single neurotoxic peptide amongst hundreds of other (mainly non-
neurotoxic) peptides. Furthermore, this part of the study gives information on the expected limits of 
detection (LODs) for the venom toxins with respect to their biochemical and MS detection. 
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Figure 30 | The applicability and performance of the analytical setup was evaluated by injecting 5 µg of Vipera ammodytes (sand 
viper) venom, spiked with increasing amounts of α-Bungarotoxin (α-BTX). The mass spectrometric data represents the data 
obtained for the Vipera venom spiked with 250 ng α-BTX. Shown are the Total Ion Current (TIC) of the spiked V. ammodytes 
venom and the Extracted Ion Currents (EICs) of α-BTX (isoforms 1 and 2 which both elute as two peaks, as also previously 
reported in literature). Reference peptides allow for alignment with other chromatographic systems. The superimposed bioaffinity 
data represent 5 injections of the V. ammodytes venom with 0 ng, 2 ng, 10 ng, 50 ng and 250 ng α-BTX. The venom analysis 
without α-BTX (trace A) obtained a previously unreported V. ammodytes ligand as is marked by the green circle (corresponding 
EIC is also shown). Nicotine was added for alignment of the mass spectral data with the bioaffinity data. This experiment was 
repeated without V. ammodytes venom (data not shown) where 1 ng, 2 ng, 10 ng, 50 ng and 250 ng α-BTX were injected. 
Chromatographic and mass spectrometric performance where comparable to this figure, while the bioaffinity data clearly showed 
the absence of the V. ammodytes  venom ligand binding to Ls-AChBP. 
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As can be seen in Fig. 30, α-BTX elutes from the reversed-phase LC column as two iso-forms in 
4 peaks, a separation profile earlier reported by245,246. This profile can be easily mistaken for being 4 
different peptide species, but due to correlating peak shapes between the biochemical and the MS 
detection, misinterpretations like this can be avoided. The results depicted in Fig. 30 clearly emphasize 
one of the main advantages of this methodology. In contrast to reversed-phase LC separations of reduced 
and unfolded peptides in proteomics studies, the LC elution profiles of intact small proteins often do not 
give single sharp peaks. Nevertheless, the bioaffinity can be correlated to corresponding accurate masses. 
With the highest amount of spiked α-BTX (250 ng, absolute amount injected), the biochemical assay 
became saturated, indicating that practically all DAHBA tracer ligand was displaced from Ls-AChBP 
(Fig. 30, trace E). It was found that the LOD of the high-affinity ligand α-BTX (Kd of 8.59)
240 was ~2 ng 
(Fig. 30, Trace B) in the biochemical assay and ~25 times higher with MS. 
Although the system showed to be very reproducible, sometimes, and especially when samples 
were repeatedly measured over several days, retention times shifted slightly (data not shown). This is a 
known issue with nano-LC systems and in our case did not impose serious problems as the biochemical 
data and MS data were measured simultaneously and despite the shifting retention times, the correlation 
remained accurate. Additionally, three reference peptides were introduced to enable alignment of 
chromatograms from different runs, and to allow for convenient transfer of the methodology and samples 
analyzed to other laboratories, if necessary. In addition, α-BTX was also analyzed separately without the 
viper venom. This resulted in similar biochemical detection signals, while only α-BTX peaks were 
observed in the LC-MS data (data not shown). These data confirm that the biochemical assay gives 
similar results for α-BTX, whether present in a complex venom sample or injected separately, thus also 
ruling out matrix effects. Finally, in these standard addition experiments, a viper venom peptide was 
found with affinity for Ls-AChBP, as is observed in the in Fig. 30 trace A (encircled green), as discussed 
below. 
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Snake venom analysis 
Snake-venom proteomes consist of a complex cocktail of peptides, which during millions of years of 
evolution, evolved into highly active ligands towards enzymes and receptors. In general, the Viperidae 
family geared its venom to affect the function of various blood components, while the family Elapidae 
(including several species from the Colubrid colubrinae subfamily) mainly developed a venom system 
with neurotoxic and cardiotoxic peptides107,176 - although this is by no means a golden rule and there are 
many exceptions to be found in both families. The three-finger toxins (3FTX) – a major and diverse 
family of low-molecular weight (<10kDa) neurotoxins - share a common tertiary structure. This main 
body is shaped by four disulfide bridges, truncating the amino acid sequence in such a way that three 
loops are formed (hence the three “fingers”).  All extant members have retained their peculiar “three-
fingered” molecular scaffold whilst exhibiting a diversity of different functions47. However, despite 
retaining the common three-finger motif, members of this family have since evolved a myriad of different 
functions182. These include effects on: platelet function247, different receptors associated with 
neurotransmission248-254; ion channels255-257,257, viability of cardimyocytes258 and red bloods cells259, 
mitosis and apoptosis260; and effects on the cell membrane261,262. The different 3FTX members also vary 
considerably in binding affinity for the different receptors263 and are important research ligands for 
studying receptors264-266. Homologous 3FTXs are found in all advanced snakes: Elapidae35 (cobras and 
relatives), Viperidae194 (vipers and pitvipers), and others4,227,267.  Not only their tertiary structure, but also 
their chain length is similar. Type I (or short-chain) neurotoxins and cardiotoxins usually contain 60 to 62 
amino acid residues, while the Type II (or long-chain) neurotoxins comprise 70 to 80 amino acids182. 
Furthermore, these peptides show 40 – 50% amino acid sequence homology. The target affinities of these 
peptide toxins are ‘tuned’ by mutations in the extremities of the three loops, as this is where interactions 
with protein targets take place. For the neurotoxic peptides, the amino acids in the ‘fingertips’ of Loops I 
and II are most determining. Type I and Type II neurotoxins bind competitively to (postsynaptic) 
nicotinic acetylcholine receptors (nAChRs). These neurotoxins are commonly known as α-neurotoxins (α-
NTXs)49,225. Besides an elongated c-terminus, the Type II α-NTXs differ from Type I by an additional 
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disulfide bridge at the extremity of Loop II. This difference causes the Type I α-NTXs to mainly target 
muscle α1 nAChRs, while Type II α-NTXs also target α7 nAChRs. The cardiotoxic (CTX) peptides are 
essentially cytotoxic peptides as they disturb membrane structures of a range of excitable and non-
excitable cells268. Most likely, similar to the neurotoxins, there is a wide range of receptors and 
(ion)channels targeted by the CTX peptides268-270. Although mainly α-neurotoxins from Elapidae have 
been associated with nAChR binding, toxins from the Viperidae have also been reported to show (low) 
nAChR affinity. In these venoms, phospholipases A2 A (PLA2s) rather than 3Ftxs are responsible for the 
neurotoxic effects. This family of toxins typically contains seven disulfide bridges and a peptide-chain 
length of 115 to 139 amino acids. It was reported that crude viperid venoms also block nAChRs (and 
voltage-gated Ca2+ channels) in isolated identified neurons of L. stagnalis271. Subsequently, they showed 
that an isolated PLA2 called Bitanarin has affinity for human α7 and Torpedo californica nAChRs, as 
well as for the AChBP (from L. stagnalis). This novel ligand is structurally similar to (smaller) PLA2s 
and shows PLA2 like activity, although it has 14 disulfide bridges and a peptide-chain length of 138 
amino acids271. Table 3 provides a summary of all peptides, which were mass-correlated with literature 
via Uniprot. Most toxins have cysteine bridges and we measured the intact peptides. Since Uniprot and 
most literature give nominal masses from the reduced peptides, the known difference in molecular mass 
(2 Da per cysteine bridge) was taken into account when the number of cysteine bridges was known. In our 
case, most of the known bioactive peptides found had 4 or 5 cysteine bridges, implying a molecular mass 
difference of 8 or 10 Da, respectively. The toxin nomenclature used for the identified toxins, by 
correlation of nominal masses of bioactive peptides found per snake with literature, is done according to 
(ref 227), and/or given as Uniprot identifier for easy reference. 
2
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Table 3 | The table on the next page shows the accurate mass of the most abundant charge state of each bioactive peptide, the 
corresponding nominal peptide mass, the toxin family the peptide belongs to (when identified and known), the corresponding 
accession number and their possible mechanism of action. All peptide masses reported in the table and in the following 
discussion are nominal masses and are correlated with masses found in Uniprot by searching the venom proteomes of the 
respective snakes profiled. Peptides not correlated in this way are referred to as ‘peptide #’. 
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Results   
Sand viper (Vipera ammodytes) 
As discussed in the previous section, a viper ligand was detected from a 5 µg total venom sample. Figure 
S1 shows both the mass spectrum and the biochemical detection signal of this analysis. Upon increasing 
concentrations of α-BTX, this viper bioactive is quickly masked by the highly active α-BTX standard. 
Table 1 additionally shows mass spectrometric information of this ligand, which could not been identified 
and is called peptide 1. 
 
Figure 31 | The ligand (peptide 1) obtained from the 5 µg Vipera ammodytes (sand viper) venom analysis. The most abundant 
charge state corresponds to total peptide mass of 13857 Da. Reported Viperidae neurotoxic phospholipases in this mass range 
typically contain 7 disulphide bridges. Hence the nominal mass of this ligand is probably 13871. 
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Mozambique spitting cobra (Naja mossambica)  
The analysis of Naja mossambica venom is a good example how neurotoxic ligands can be screened by 
the miniaturized on-line HRS methodology, effectively narrowing down the number of probable and 
possible ligands. When correlating the extracted ion chromatograms (EIC) with the biochemical detection 
signal of a 5 µg Naja mossambica venom analysis, three strong binders and one weaker binder were 
detected. Their nominal masses correlate with peptides P01469, P01470, P01467 and P25517 respectively 
(Fig. 32).   
 
Figure 32 | 5 µg injection of Naja mossambica (Mozambique spitting cobra) venom. Three strong binders and one weaker binder 
were detected (P01469, P01470, P01467 and P25517 respectively) which were preciously reported as Type IA cytotoxins, a 
group consisting of cytotoxins and cardiotoxins. 
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The first three of these peptides (P01469, P01470 and P01467) share a >90% homology, whereas 
P25517 has a ~80% homology with the very high affinity ligands as deduced from a Blast search in 
Uniprot. These toxins have been classified by (ref 227) by homology to the group Type IA cytotoxins, a 
group of cardiotoxic and cytotoxic toxins. Interestingly, these four particular toxins have also been found 
to form a clade separate from the Type IA cytotoxins227, including being separated from other African 
cobra species because of their amino acid sequence divergence level. Furthermore, these authors 
suggested comparative assaying to determine differences in potency or specificity between these toxins 
and the Type IA group of cytotoxins227 – that normally exhibit cadiotoxic and cytotoxic effects. Indeed, 
this proved to be a valid suggestion as we found these toxins showed relatively high affinities to the 
model Ls-AChBP target and are thus likely to be neurotoxic. This, to our knowledge, has not been 
reported before. These toxins, together with the highly homologous toxin P01468 from the venom of the 
Naja pallida (closely related to N. mossambica) that is the only other found in the clade of (ref 227) could 
form a new group of so-called Type IV α-neurotoxins because of their affinity/functionality but being 
distinctly different in their sequence than, for instance, the Type I α-neurotoxins. So far, predominantly 
3FTX-type cardiotoxins have been reported in comprehensive venomics studies on the composition of the 
Naja mossambica venom272. In addition, two Type I α1 nAChR ligands have been reported (NMM I and 
NMM III), one of which was also observed in our LC-MS analysis. It has been shown that this peptide 
(‘NMM I’ or ‘P01431’ 62 amino acids (reduced) molar mass 7081 Da, most abundant charge state m/z 
1415,635 ), binds exclusively to muscle type α1-nAChRs273,274. In our analysis, this peptide did not show 
affinity towards the AChBP (Fig. 32).  
Initially, 5 µg of venom was injected for analysis to a) also observe low-affinity and/or low-
abundant binders, and b) to provide sufficient sensitivity in MS. This, however, resulted in severe peak 
broadening for the high-affinity and/or high-abundant bioactive peptides, as can be seen in Fig. 32. 
Subsequently, lower venom concentrations were injected and analysed. In this case, sharper peaks were 
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observed and correlations were more straightforward, which assisted in the total elucidation process (Fig. 
33).  
 
Figure 33 | For more straightforward correlation between the mass spectrometric data and the bioaffinity data, 1.5 µg Naja 
mossambica (Mozambique spitting cobra) venom was injected, which obtained sharper peaks and less co-elution of toxins than 
the 5 µg injection (Fig. 32). To demonstrate the effect of a chromatographic run in terms of selectivity, the pH of the reversed-
phase LC run was increased from pH 2.5 to pH 7.5 (data not shown). This resulted in an elution order change where P01469, 
P01470, P01467 (at pH 2.5) shifted to P01469, P01467, P01470. As a result of shifting retention times another probable ligand 
could be detected (peptide 2 (Table 3)) with a mass of 15.186.  
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In order to test P01469, P01470, P01467 and P25517 for α7-nAChR affinity in an off-line 
radioligand assay, these toxins were separated and fractionated on a normal bore LC-column (4,6mm x 
100mm column Symmetry Shield, Waters Etten-Leur, the Netherlands). For the ‘large bore’ LC 
measurements, 2.5 mg venom was injected at 2.5 mL/min under the same gradient conditions. The 
fractions were subsequently lyophilized, re-dissolved in water/ACN/TFA 95:5:0.1% and injected in the 
on-line miniaturized assay to check for purity and activity. It was found that after fractionation, 
lyophilisation and re-desolvation most activity was diminished (data not shown). Experiments were 
carried out such as collecting the fractions in 50 mM ammonium bicarbonate to neutralize the TFA in the 
LC carrier fluid, but this did not significantly increase activity. 
 
Jameson’s mamba (Dendroaspis jamesoni kaimosae) 
From a 5 µg venom injection of the Dendroaspis jamesoni kaimosae (Jameson’s mamba), eight ligands 
were detected in the biochemical detection signal (Fig. 34). The first (weak) binder, eluting at 33 min, can 
be mass-correlated to a peptide (P01417) first reported by (ref 275) as a (weak) nAChR neurotoxin based 
on anti-venom affinity for the homologous cobra venom. This toxin was then classified as a Type I α-
neurotoxin227. The massive bioactive peak at 39 min is caused by two peptides (peptide 3 and peptide 4) 
which could not be mass-correlated with literature. The fourth affinity peak at 44 min was attributed to 
either co-eluting P25682 or peptide 5. P25682 has been classified an orphan toxin XIX (a group of 
Dendroaspis and Bungarus toxins of unknown function / protein target)227. The onset of binding signal at 
48 min is probably caused by peptide 6, whereas the remaining signal is caused by P01406, which has 
been classified as an orphan group XI toxin (of unknown function/target)227. P01406 elutes in two forms, 
also causing another binding signal at 55 min. The small binding signal at 62 min is caused by peptide 7, 
whereas the last signal at 77 min can be attributed to P01418, which has been classified as a Type I α-
neurotoxin227. 
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Figure 34 | Typical result of a crude snake venom analysis where 5 µg  of Dendroaspis jamesoni kaimosae (Jameson’s mamba) 
was injected. This analytical run obtained 10 ligands of which 3 are previously reported on in literature; classified as either 
muscle type neurotoxin or orphan ligand. The venom analysis was repeated with a 1.67 µg injection (Figure 4b) to provide for 
better chromatographic peak shapes enabling more straightforward correlations. Consequently, less ligands were detected at this 
venom concentration as some lower affinity neurotoxins reached their level of (biochemical) detection. 
A lower, 1.67 µg venom injection provided better chromatographic peak shapes enabling more 
straightforward correlations (data not shown). In conclusion, the majority of the peptides found in the 
Dendroaspis jamesoni kaimosae venom require subsequent purification of the unknown co-eluting 
peptides followed by comprehensive functionality assaying and sequencing. This, however, is beyond the 
scope of the current work. 
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African cobra (Naja annulifera) 
From a 5 µg Naja annulifera venom injection, clearly three binding signals can be observed (Fig. 35). 
The two binding signals eluting at ~ 65 min can be attributed to P62390 and P01461, first reported by (ref 
276). The latter has been classified a Type IA cytotoxin227. P01461 sequence-wise is not part of the African 
Spitting cobra’s ‘divergence clade’ mentioned above, although it shares 81% homology with Naja 
mossambica’s P01467. The binding peak shows that possibly more Type IA cytotoxins exhibit neuronal 
α-neurotoxicity. P6290 has not been classified by (ref 227), but by sequence similarity it mostly resembles 
the ‘orphan group XV’ toxins (via Blast search in Uniprot), a group coined with only limited known 
biochemical function besides probable ‘low-level cytotoxicity’ for Naja toxins227. P6290 shares, for 
instance, 90% homology with P1541, a Naja kaouthia toxin classified as orphan group XV type227.  
As the MS signals of these peptides are quite high, while the affinity signals are (relatively) low, 
P62390 and P01461 are probably low-affinity binders. Based on the same criteria, the main ligand eluting 
between 40 and 50 min is a low-abundant, high-affinity ligand. From the initial analysis at pH 2.5, two 
co-eluting ligand peptides were identified, which could be mass-correlated with P25674 and P01399 from 
Naja haje haje (Egyptian cobra). When repeated at pH 7.5, P25674 and P01399 showed improved 
resolution (data not shown). In addition, the MS intensity of peptide P25674 increased, making 
correlation with the bioaffinity signal more straightforward. P01399 was first reported by (ref 277) and 
classified as a weak cytotoxin. A homologue of this peptide has also been found in the Naja sputatrix 
(Indonesian spitting cobra (Q802B2); with 82% homology) and is reported as a weak (muscle type) 
nAChR ligand278. 
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Figure 35 | Analysis of 5 µg Naja annulifera (African cobra) venom obtained three binding signals . The first, large binding 
signal can be attributed to a highly active α-cobratoxin ligand P25674 (a toxin which has been reported in the venom of N. haje). 
The two latter binding signals were correlated to P62390 and P01461 (previously classified as Type IA cytotoxins). As the α7 
ligand P25674 co-elutes with toxin P01399, the analysis was repeated at pH 7.5 (data not shown). P25674 and P01399 showed 
improved resolution and the MS intensity of peptide P25674 increased. Again this clearly shows the value of the higher pH 
analysis ‘mode’. The analysis was thereafter repeated by injecting 1 µg and 0.2 µg venom (data not shown), which not only 
allows for more precise correlation between the MS and bioaffinity data sets, but also demonstrates the repeatability of the 
system. 
The main neurotoxic ligand in the Naja annulifera venom, P25674, was identified by its 
homologue reported in the Naja haje haje venom, which contains a peptide with an identical mass and has 
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been reported as a highly active α7 ligand279. As these cobra subspecies share many homologues toxin 
peptides, it can be assumed that this particularly high-affinity peptide has been 100% conserved in 
sequence in both species.  Although it has to be taken into account that in the 70s and 80s many venoms 
came from species that were mis-identified280, so it cannot be ruled out that the Naja haje haje venom 
used in (ref 279) was in fact Naja annulifera venom. Lower amounts of venom injected (1 µg and 0.2 µg) 
provided better chromatographic signals allowing for more reliable biochemical correlations (data not 
shown). The caveat mentioned earlier and also the rationale for injecting a high amount of venom for 
analysis: the major bioactive was not observed in MS anymore when looking at the amount of 0.2 µg 
injected (data not shown). This can easily lead to misinterpretations. Therefore, in some cases like the one 
described here, different concentrations need to be analysed in order to reach a high confidence regarding 
correlation of bioactives to their identity. As one additional  analytical run with a lower concentration 
injected takes less than two hours, this is not a significant problem. 
 
Cape cobra (Naja nivea) 
Naja nivea is closely related to other African cobras such as the Naja haje and Naja annulifera, as can be 
traced back to its venom, having a high-affinity α-cobratoxin and several low-affinity Ls-AChBP binders 
(Fig. 36). At least five ligands could be detected from analyzing 5, 1 and 0.2 µg crude venom samples. 
The high-affinity binder at 39 min, P01390, is a Type II α-neurotoxin227. As due to column overloading a 
small percentage of the total bioactive P01390 slowly elutes from the column in a tailing fashion, the Ls-
AChBP affinity of the remaining neurotoxins is somewhat harder to distinguish (see Fig. 36). This again 
shows the potential problem of seemingly severe peak broadening when very high-abundant and/or high-
affinity ligands are present in a venom sample. It has to be noted that the bioaffinity signals are sigmodial 
in their response and not linear. This results in seemingly very severe peak broadening in the bioaffinity 
trace, while this is not observed in the parallel MS (or UV) response. This indicates that it is in fact not 
severe peak broadening but due to an intrinsic characteristic of biochemical detection in general.  
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Figure 36 | Injection of 5 µg of crude Naja nivea (Cape cobra) venom obtained at least 5 ligands. The binding signal at 39 
minutes can be attributed to the high-affinity α-cobratoxin P01390. As this strong binder elutes from the analytical column in a 
very broad peak (and thereby overloading the bioaffinity signal) the remaining toxins are hard to distinguish (such as toxin 
P25680). This was resolved by injecting smaller concentrations of venom, as seen in Figs. 37 and 38.   
Closely eluting to the high affinity binder P01390 is P25680, an orphan group II toxin227. It could be a 
low-affinity binder, but due to the high-binding signal of P01390 no conclusions can be drawn. The 
bioactivity signal at 57 min can be attributed to P01456, classified as a Type IA cytotoxin227. The binding 
profile at 64 min is caused by a peptide (peptide 9) could not be mass-correlated with literature data. At 
67 min, the peptide is most probably binding to AChBP is P01463, which is classified as an α1 nAChR 
ligand. But AChBP bioaffinity of the co-eluting peptide 8 cannot be ruled out. As also shown for the Naja 
mossambica, Dendroaspis jamesoni and Naja annulifera venom analysis, analyzing lower concentrations 
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of the Naja nivea venom assisted us in more accurate mass-correlations of bioactives, thus facilitating 
their identification.  
 
Figure 37 | Injection of 5 µg of crude Naja nivea (Cape cobra) venom. From the lower concentration venom analysis it was 
possible to correlate at least four other toxins, of which three are classified as Type IA cytotoxins (P01456, P01463 and P68419) 
while the other two toxins are not reported on.  
The data in these analyses are complementary: while the major bioactive peptides are readily 
detected by MS upon a 5 µg injection, their detection becomes more difficult or even impossible at 1 µg 
(Fig. 37) and 0.2 µg analysis (Fig. 38). However, in the biochemical detection, the smaller sample 
injections result in increased chromatographic resolution and allow the minor bioactives to be analyzed 
more clearly. 
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Figure 38 | Injection of 0.2 µg of crude Naja nivea (Cape cobra) venom increased chromatographic resolution and allowed minor 
bioactives to be analyzed more clearly.  
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Discussion and perspectives 
The AChBP is an established structural homologue of the α7 nAChR, a (potential) drug target for pain 
syndromes, cognitive and neurodegenrative diseases. As Type II α-NTXs are high-affinity binders to the 
α7 nAChR, AChBP is a valid and very useful water-soluble target model to screen for high-affinity 
binders in these venoms. Snake venoms might contain potential biopharmaceuticals. In case of neurotoxin 
venoms, particular interest is in targeting nAChRs, e.g., the α7 nAChR. Besides discovery of such 
potential biopharmaceuticals, screening of venoms may also yield valuable tool compounds with high 
affinity towards specific ion channels, which can be used as tools for biological and pharmacological 
studies281,282. Typical examples of such snake toxin peptides are the α-bungarotoxins and α-
cobratoxins240,283,284. This study showed that screening of snake venoms using the HRS approach with the 
Ls-AChBP yields not only many high-affinity peptide/protein ligands, but also low-affinity Ls-AChBP 
ligands, which were reported upon in the literature as Type I α-NTXs, cardiotoxins and PLAs. In 
addition, several other bioactive peptide ligands were found that were previously unreported or reported 
as orphan-ligands, of which the biological function is presumed, only based on sequence homology.  
The data obtained from screening Naja mossambica venom clearly shows that ligands still can be 
identified even though the peptides are closely eluting in relatively broad peaks. For the screening of 
Dendroaspis jamesoni kaimosae venom, this is shown again, but here the number of ligands found is 
substantially higher, which makes ligand identification more complex. Here, low-affinity binders are first 
identified by injecting a higher concentration sample, followed by an analysis of more diluted sample(s) 
to distinguish ligands with high affinity from low-affinity ligands. In the third snake venom profiled, a 
strategy is shown in which co-eluting peptides from Naja haje annulifera venom (of which one has a very 
high affinity towards Ls-AChBP) are correlated with the biochemical detection signal with higher 
confidence by means of changing the selectivity of the reversed-phase LC separation followed by 
reanalysis of the sample. This strategy, where an additional chromatographic run was performed at a high 
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pH, narrowed possible ligands significantly. The last example showed how a serial dilution analysis of 
Naja Nivea venom enabled the detection of 5 possible AChR ligands.  
As described in the method evaluation, the structure of venom peptides is highly conserved in 
their evolutionary trail causing their chromatographic behaviour also to be similar. Besides poor 
separation because of many iso-toxins166, also bad chromatographic peak-shapes pose an analytical 
challenge. Even though these characteristics result in often challenging chromatographic separations, 
peptide ligands could be identified by direct correlation of the biochemical detection signal with the EICs 
from MS as obtained from the IT-TOF MS measurements. Once correlated, these masses give an idea of 
the identity of peptides (e.g. Type 1 or Type 2). As the correlated masses found are exact (measurements 
are performed by an accurate and high resolution MS), these masses furthermore provide for a 
straightforward and targeted fractionation approach. After chromatographic purification, a validation can 
be performed by re-analyzing the purified sample, followed by further structural elucidation by e.g. 
tryptic digestion and novo-sequencing, Edman degradation and receptor binding and activation studies.  
This study described the evaluation, validation and demonstration of the potential of our 
miniaturized on-line HRS approach for comprehensive profiling of snake venoms with respect to nAChR 
affinity. Snake venoms of Vipera ammodytes, Naja mossambica, Dendroaspis jamesoni kaimosae, N. 
annulifera and N. nivea were analysed yielding data on both the accurate molecular mass and identity of 
the peptides present and their individual bioaffinity towards the AChBP.  
Conclusion 
As is well known, animal venoms provide for numerous ligands towards a myriad of receptors, enzymes 
and ion channels and therefore have the intrinsic potential to modulate biological and pharmaceutically 
relevant signal cascades. This study describes the application of a miniaturized on-line analytical 
methodology where neurotoxic (Elapidae) snake venoms are screened for toxins with Ls-AChBP affinity, 
mimicking binding to neuronal nAChRs, especially α7 nAChR. Prior to snake profiling, a post-column 
nano-split was developed and implemented followed by evaluation and validation of the methodology. 
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The methodology proved to be suitable for profiling of snake venoms. By correlating bioactive peptides 
with their mass identified we were able to identify bioactives. In many cases, toxins described in literature 
are only correlated to a possible function by amino acid homology only. 
We found 11 peptides that were not previously correlated with neuronal nAChR affinity and 
therefore are interesting molecules for further studies on their biological interactions with nAChR. As 
discussed, many of the toxins sequenced and described in literature are classified by function only by 
their homologies towards toxins of which the protein target / biological function is known. Although 
subsequent in-depth studies of the toxins described in this study for nAChR binding are needed, their 
affinities towards the Ls-AChBP give a good hint of (one of) their function(s): i.e. targeting the nAChRs 
to causing immobilization of the prey animal. Besides these orphan toxins described, also 10 unknown 
proteins were found, which are in need of additional sequencing and functional assaying. Even though 
only the long neurotoxins (Type II) have been correlated with the neuronal α7 nAChR, most of the 
peptides that were found in this study were short neurotoxins (60 to 64) amino acids. All short 
neurotoxins described in literature are 6700-6900 Da. Four previously sequenced toxins were found in 
Naja mossambica venom. Although these toxins were classified as cardiotoxins, they did show significant 
binding to Ls-AChBP. However, further functionality assaying is required to validate human (neuronal) 
activity. Attempts to do this by fractionation failed as most activity was lost in the lyophilisation 
procedure. This shows the value of our ‘on-line’ method as no additional lyophilisation process is 
required. Therefore, probably, our methodology suffers less from false negatives. Venom analysis from 
Dendroaspis jamesoni kaimosae yielded two ligands known as α1 nAChR ligands, while two other 
binders are classified as orphan ligands. Further studies are required to validate these results, as for the six 
other (possible) neuronal nicotinic acetylcholine receptor ligands found in this venom proteome, which, to 
this date, are not described in literature. The main binder in the Naja annulifera proteome was attributed 
to a known α7 nAChR binder, of a closely related Naja haje haje, while two other distinct ligands are 
correlated to toxins described in literature as cardiotoxin only. The analysis of this particular venom 
shows the benefit of analysing at both a high and low pH, as this caused selectivity changes in the 
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reversed phase LC separation leading to more straightforward correlation of the bioactivity and the mass 
spectrometric detection of a low abundant, high affinity ligand. The Naja nivea venom proteome shows 
four distinct binding ‘curves’ which can be attributed to five ligands; the largest signal is caused by the a 
known α7 ligand, while the three other curves can be attributed to tree ligands previously described as 
cardiotoxin and two unknown peptides, of which one co-elutes with one of the cardiotoxins. 
The rapid and high resolution screening of these five venom proteomes shows the potential of the 
here described microfluidic on-line screening technique. Not only did the application of this technique 
show the analysis speed, it also demonstrates the advantage of the direct post-column analysis, as 
fractionation and lyophilisation causes the deactivation of toxins, which in previous runs did show 
significant signals in the on-line Ls-AChBP assay. Furthermore, by the coupling of a miniaturized 
separation technique (nano-LC) to a microfluidic on-line assay and sensitive fluorescence detection, we 
showed that multiple, sensitive and robust analyses are possible with only a minimal amount of (the very 
precious) venom required. In the future, it may be possible to combine these technologies with the 
emerging microfluidic whole-animal assay systems such as those being developed in our lab for zebrafish 
embryos285. 
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Chapter 7: Summary and Discussion  
Snakes are a fascinating and intriguing group of vertebrates that have gone to extremes in adaptation. 
Their venom system belongs to one of the most sophisticated natural weapons systems in the natural 
world. It is composed of a venom gland, duct and fang, and in some phylogenetic groups an accessory 
venom gland. In Chapter 2 we have elucidated the evolution of the different types of snake fangs. There 
are three distinct groups of snake fangs found. The first is a rear-fanged type, where the fangs are 
positioned in the rear of the upper jaw and this fang-type is found in most snake species. Then there are 
two types of front-fangs found. The first is found in vipers and pitvipers, where the fangs are often large 
and lie recumbent in the upper jaw. They are mobile and can move back and forth. The second type is the 
one found in cobras and mambas and relatives and is smaller and immobile. Because these two groups do 
not form a monophyletic group, the evolution of these different fang types has always been subject to 
debate. We have collected many different snake embryos of all three groups and looked at the 
development of the dentition using the Sonic hedgehog gene as a marker. Using in situ hybridization 
followed by careful 3D reconstruction we could follow the development of the fang. Our results showed a 
great amount of similarity in morphogenesis of the fang of the three different groups of snakes. The two 
front-fangs start right at the base of the rear of the upper jaw in development, just as the rear-fang. The 
only difference is that the two front-fangs move forward in development by ontogenetic allometry 
(pushing the fang forward due to rapid growth of the upper jaw behind the fang) to its adult front position. 
Also, we showed that the rear-fang develops from its own dental lamina instead of with the same dental 
lamina as the front 'normal' teeth. It was this posterior dental lamina that showed great similarity to the 
dental laminae in the two front-fang snake groups. Our results thus suggest a scenario in which all three 
fang-types are homologous and descendent from a rear-fanged ancestor (by means of uncoupling the 
posterior from the anterior teeth), after which the two front-fanged groups moved their rear-fang forward 
during evolution. This probably allowed them to feed on larger and more dangerous prey items as a quick 
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'snap-and-release' was made possible by the front-fangs compared to the 'bite-and-hold-on' that is only 
possible with rear-fangs.   
Another extreme of adaptation in snakes is their body elongation. Snakes have elongated bodies 
with numerous vertebrae, some even up to 500 of them. They have lost most clear morphological 
boundaries in their adult bodies. This has been of major importance in the evolution of the venom-
delivery system, as snakes use their elongated bodies as a coiled spring that can strike prey at a distance 
and with terrifying speed, injecting the immobilizing venom. Without elongated bodies able to strike and 
bite, their venom-delivery systems (especially the fangs) would probably have evolved in a completely 
different manner. In chapter 3 we have analyzed and examined the expression of Hox genes in different 
snake embryos from different stages to examine the evolution of s serpentine body form. Hox genes 
determine the basis structure of animals, and it was assumed that the species with a snake-like body 
evolved such a body by a homogenization of the Hox expression domains along the primary axis. 
However, in our extensive analysis using in situ hybridizations we have found - on the contrary - that 
snakes do retain a collinear expression of the Hox genes in the developing embryo. Some Hox genes 
boundaries correspond to expected anatomical boundaries (the most anterior and posterior Hox genes), 
but many do not. The dorsal (thoracic), homogenous rib-bearing region of trunk has also retained 
regionalized Hox expression that is not obviously reflected in the anatomy. Our results suggest that the 
evolution of a deregionalized, serpentine body involved not only alterations in Hox gene cis-regulation 
but also a different downstream interpretation of the Hox code.  
The snake venom secretions themselves consist of a complex mixture of proteins and pepties that 
have evolved to target important physiological pathways and immobilize prey items. These toxins are of 
major evolutionary and biomedical interest. From an evolutionary perspective, they undergo an 
accelerated form of evolution. The genes undergo accelerated evolution due to a larger amount of 
mutation in coding regions than in non-coding regions, while in almost all other known genes in the 
natural world this is the other way around - except the genes in the immune system. This allows fast 
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evolution and adaptation towards ever changing prey and prey physiology (evolution of resistance). In an 
analogous manner, our immune systems must fight ever changing pathogens. This arms-race is the 
driving force behind diversity. From a biomedical perspective, this diversity is right at the base of why 
snake venoms form such a potential goldmine for new pharmaceuticals.  In chapter 4 we have sequenced 
the king cobra (Ophiophagus hannah) genome to look at the evolution (and recruitment) of the venom 
genes. They are thought to have evoloved from normal, physiological genes by means of gene duplication 
followed by selective expression in the venom gland. However, in the absence of genomic resources these 
hypotheses remain mainly speculative. Our results show that venom genes evolve through distinct 
mechanisms. L-amino acid oxidase, cysteine-rich secretory proteins and metalloproteinases, evolved by 
tandem-duplication of ancestral physiological genes, followed by recruitment through selective 
expression in the venom gland. By contrast, nerve growth factor toxins appear to have evolved by 
duplication and dual recruitment, while hyaluronidase and phospholipase B evolved by recruitment of 
existing physiological genes without further duplication. The massive toxin families the 3FTXs and the 
PLAs have undergone extensive duplications that have resulted in (at least) 21 copies in the genome. 
These results show a much more dynamic evolutionary history in venom genes as previously assumed. It 
is yet unclear what is causing the recruitment into the venom gland, and we are currently working on 
answering this question.  
The enormous diversity in venom genes, caused by the different ways of evolution and 
recruitment as shown in chapter 5, makes it a challenge to identify bioactives for a particular receptor in 
order to either study the venom for evolutionary studies, or to find new pharmaceuticals. In addition to 
this, the extreme low venom yield that most snakes have make it a very precious sample. For most 
traditional methods of evaluating a sample with mass spec and bioactivity studies you need a relatively 
large amount of venom, which is a major challenge for many species. We have developed in chapter 6 a 
new method to study the make-up of the venom and - at the same time and in the same run - look for 
bioactives that bind to acetylcholine binding protein. One test used up less than 5 ug of venom and took 
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less than 2 hours. We found 21 bioactives of which 7 were never reported on before. This technique 
includes a microfluidic on-line screening approach utilizing nano-LC–MS with parallel bioaffinity 
detection using  the acetylcholine binding protein (AChBP). The system comprises a post-column nano-
flow split which directs the chromatographic effluent to mass spectrometric and on-line biochemical 
detection allowing for simultaneous correlation of separated bioactive venom toxins with their 
corresponding accurate mass.  
In conclusion, in this thesis I have shown that snakes have undergone multiple changes in their genome 
and embryonic development that has provided them with the variation to which natural selection could 
act. This thesis provides evidence for the variable mechanisms of venom gene evolution, which 
presumably is much more flexible than previously thought. But it also underscores the potential use of the 
many different types of snake venom toxins that could be screened for use against human disorders. And 
most of all, I hope I have contributed towards the fact that snakes are just an incredibly interesting group 
of vertebrates from both the perspective of ecology and life-style, as well as from a genomic and 
molecular perspective. They are, and will always be, my first and true love.  
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Samenvatting en Discussie  
Slangen zijn een fascinerende en intrigerende groep gewervelde dieren die tot extremen zijn gegaan in 
evolutionaire adaptatie. Het gifsysteem is bijvoorbeeld een van de meest geavanceerde biowapensystemen 
uit de natuur. Het omvat een gifklier, een gifkanaaltje, een giftand, en in sommige fylogenetische groepen 
een ‘accessory gland’. In hoofdstuk 3 hebben we een hypothese opgesteld voor de evolutionaire 
oorsprong van de verschillende typen giftanden. We kunnen drie typen van elkaar onderscheiden. De 
eerste is een kleine, onbeweeglijke giftand die achter in de bek staat, en dit type giftand vinden we bij de 
meeste slangensoorten. Dan zijn er twee verschillende typen van giftanden die voorin de bek staan. Het 
eerste type is te vinden bij de familie Viperidae, dat bestaat uit adders en ratelslangen (groefkopadders). 
Hierbij zijn de giftanden vaak groot en liggen ze horizontaal in de bovenkaak. Ze zijn beweeglijk en 
kunnen op en neer bewegen door een scharnier. Het tweede type is te vinden in de familie van de 
Elapidae, de cobra’s, mamba’s en verwanten. Hier is de giftand vaak kleiner en onbeweeglijk. Omdat 
deze twee families geen monofyletische groep vormen, is de evolutie van deze giftanden onderwerp 
geweest van discussie. Om dit te onderzoeken hebben wij een grote hoeveelheid slangen embryo’s 
verzameld van verschillende soorten, behorend tot alle drie de giftand typen. Hierbij hebben we de 
ontwikkeling van het gebit gevolgd met het gen sonic hedgehog als marker. Door middel van in situ 
hybridisatie en 3D reconstructie konden we de algehele ontwikkeling van de giftand in kaart brengen. De 
resultaten waren verbluffend: er was een grote mate van gelijkenis te vinden in de ontwikkeling van alle 
drie de typen. Bij de Elapidae en de Viperidae begon de ontwikkeling van de giftanden in de embryonale 
ontwikkeling bij beiden achter in de bek, net als bij de overige slangen. Het grote verschil is echter dat de 
giftanden van de Elapidae en de Viperidae tijdens de ontwikkeling naar voren werden geduwd door 
ontogenetische allometrie, doordat de kaak achter de giftand sneller groeide dan het gedeelte ervoor. Bij 
achtertand giftige slangen ontstaat de giftand vanuit zijn eigen onafhankelijke dental laminae (embryonaal 
primordium), en deze vertoont grote gelijkenis met de ontwikkeling van de dental laminea van de 
giftanden van de Elapidae en de Viperidae.  Onze resultaten suggereren een scenario waarin alle drie de 
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giftanden homoloog zijn aan elkaar, afkomstig van een giftand die achterin de bek stond. Hierna hebben 
de Elapidae en de Viperidae onafhankelijk van elkaar de giftand naar voren geschoven in de evolutie. 
Vermoedelijk kwam dit door het bijkomstig evolutionair voordeel dat deze slangen grotere en 
gevaarlijkere prooien aan konden door middel van een snelle “bijt en laat los” methode. De slangen met 
hun giftand achter in de bek kunnen dit niet, en moeten hun prooi vasthouden om gif in de wond te 
kauwen. Dit is onmogelijk bij gevaarlijke prooien zoals grote ratten.  
Slangen hebben verlengde lichamen met tot 500 wervels. Ze hebben de duidelijke morfologische grenzen 
van hun lichaam verloren die veel andere dieren (inclusief mensen) wel hebben. Het verlenging van het 
lichaam is van groot belang geweest voor de evolutie van het gif systeem, omdat slangen hun lange 
lichamen kunnen gebruiken als een springveer om prooien met grote snelheid te bijten, en gif te 
injecteren. Zonder deze lange lichamen om te bijten, zal het gifsysteem – en zeker de giftanden - 
waarschijnlijk op een hele andere manier zijn geëvolueerd. In hoofdstuk 4 hebben we de expressie van 
Hox genen bekeken in verschillende slangen embryo’s van verschillende stadia om de evolutie van een 
‘slangachtig lichaam’ te bestuderen. Hox genen bepalen de lichaamsvorm van dieren. Het was algemeen 
aangenomen dat dieren met een ‘slangachtig lichaam’ dit geëvolueerd hadden door een homogene 
expressie van Hox genen langs de primaire lichaamsas, in tegenstelling tot de altijd zo karakteristieke 
colineaire (regionaliserende) expressie. Echter, in onze experimenten met behulp van in situ hybridisatie 
hebben wij juist het tegenovergestelde gevonden. Slangen hebben wel de colineaire expressie van Hox 
genen behouden in hun embryonale ontwikkeling. De grenzen van de expressie van sommige Hox genen 
corresponderen met de te verwachtte anatomische grenzen (de most anteriore en posteriore Hox genen), 
maar bij veel andere Hox genen is dat niet het geval. Het dorsale (thoracische), homogene rib-dragende 
deel van de slang heeft ook de regionaliserende Hox expressie patronen behouden. Deze grenzen zijn 
echter niet terug te vinden in de anatomie van een slang. Onze resultaten suggereren daarom dat de 
evolutie van een gederegionaliseerde, ‘slangachtig lichaam’ niet alleen veranderingen in de expressie van 
Hox genen zelf verreist maar ook een andere downstream interpretatie van de Hox code.  
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Slangengif bestaat uit een complex mengsel van verschillende eiwitten en peptiden die geëvolueerd zijn 
om prooien te immobiliseren door bepaalde belangrijke fysiologische doelen aan te vallen. Deze 
gifstoffen zijn zeer interessant voor de evolutionaire en biomedische wetenschap. Ze ondergaan 
bijvoorbeeld een vorm van ‘versnelde evolutie’, door een groter aantal mutaties in de coderende stukken 
DNA (exons), in relatie tot de mutaties in de niet-coderende stukken DNA (introns). In de meeste genen 
is dit juist andersom. Eenzelfde patroon vinden we in de genen die betrokken zijn bij immuunsystemen. 
Wij moeten ons wapenen tegen alsmaar veranderende pathogenen, maar op een analoge wijze moeten 
slangen zich wapenen tegen alsmaar veranderende prooien die resistentie ontwikkelen. Deze 
wapenwedloop is de drijvende kracht achter de diversiteit in gif. Vanuit een biomedisch oogpunt, zijn 
deze stoffen interessant omdat ze een grote variatie vertonen en daarmee een potentiële goudmijn vormen 
voor nieuwe farmaceutische stoffen. In hoofdstuk 5 hebben we het genoom van de koningscobra 
(Ophiophagus hannah) in kaart gebracht. We hebben gekeken naar de oorsprong, evolutie en werving van 
gifgenen in de gifklier. Er werd gedacht dat gifgenen volledig evolueren door middel van de duplicatie 
van normale, fysiologische genen gevolgd door werving van de gifklier. Maar omdat er nog geen 
slangengenoom beschikbaar was, bleef dit speculatie. Onze resultaten laten zien dat gifgenen evolueren 
door meerder verschillende mechanismen, en dat de evolutie van gifgenen dus flexibeler is dan dat 
voorheen werd gedacht. L-amino acid oxidase, cysteine-rich secretory proteins en metalloproteinases zijn 
bijvoorbeeld geëvolueerd door tandem duplicatie van fysiologische genen, gevolgd door werving door de 
gifklier. Maar, nerve growth factor toxins zijn geëvolueerd door duplicatie waarbij beide kopieën door de 
gifklier zijn gerekruteerd, terwijl bij hyaluronidase en phsopholipase B geëvolueerd zijn door werving van 
al bestaande genen zonder duplicatie. De three-finger toxins en phospholipases A2 hebben beiden veel 
duplicaties ondergaan dat heeft geresulteerd in meerdere kopieën in het genoom. De resultaten laten zien 
dat de evolutionaire geschiedenis van gifgenen dynamischer is dan tot nu toe werd aangenomen. Hoe de 
gifgenen door de gifklier worden gerekruteerd is nog onbekend, maar deze vraag zal hopelijk in de nabije 
toekomst beantwoord kunnen worden door zorgvuldige analyse van de promotor regio’s in de gifgenen.  
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De enorme variatie binnen gifstoffen maken het een uitdaging om stoffen te vinden die aan een bepaalde 
interessante receptor aanhechten. Dit kan zowel belangrijk zijn voor evolutionaire studies als voor de 
zoektocht naar nieuwe farmaceutische interessante stoffen. Het feit dat slangen vaak maar een hele kleine 
hoeveelheid gif produceren maakt dit niet makkelijker. Bij de meeste traditionele methodes waarbij een 
monster wordt geanalyseerd met massaspectrometrie gevolgd door een zoektocht naar een bepaalde 
bioactieve stoffen is een relatieve grote hoeveelheid van het monster nodig, wat een uitdaging is bij veel 
soorten slangen. In hoofdstuk 6 hebben we een nieuwe methode ontwikkeld waarbij we in een run zowel 
de samenstelling van het gif via massaspectrometrie kunnen bepalen, als ook bioactieve stoffen kunnen 
vinden die hechten aan de zogenaamde acetylcholine binding protein (een analoog van de acetylcholine 
receptor, die vermoedelijk betrokken is bij verscheidene menselijke aandoeningen). Voor het uitvoeren 
van een enkele test hebben we minder dan 5ug gif nodig, en minder dan twee uur tijd. We hebben 21 
bioactieve stoffen gevonden, waarvan 7 nog niet waren gerapporteerd. Deze techniek omvat een 
microfluidics on-line screening dat een nano-LC-MS gebruikt, met daaraan gekoppeld een bioaffinity 
detectie met de acteylcholine binding protein. Hierdoor kan het systeem (dat gebruik maakt van een post-
column nano-flow split) gelijktijdig de gescheiden bioactieve gifstoffen correleren aan hun bepaalde 
massa.  
Ik heb in dit proefschrift laten zien dat slangen verscheidene veranderingen in hun genoom en embryonale 
ontwikkelingen hebben ondergaan die ze de variatie hebben gegeven waarop natuurlijke selectie druk kon 
uitoefenen. Ik heb in dit proefschrift bewijs geleverd dat gifgenen op verschillende manieren evolueren, 
en daarin meer flexibel zijn dat gedacht werd. Ik onderstreep ook de potentie die de verschillende stoffen 
in het slangengif hebben  voor de farmaceutische wetenschap. Maar bovenal, heb ik hopelijk bijgedragen 
aan het feit slangen een waanzinnig interessante groep gewervelde dieren zijn vanuit zowel het 
perspectief van ecologie, alsook genomics en evolutie. Ze zullen altijd mijn eerste en grote liefde blijven!  
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